Steu的个人主页 - 老虎社区

Steu

Steu

暂无个人介绍

IP属地：未知

506关注

55粉丝

1主题

0勋章

2021-09-15

$AMC 20210924 48.0 PUT(AMC)$Now Im showing my position, this two day sure down one for amc, because tmr appl or spy will definately go up due to iphone 13, if u want earn more money, trust me, just put for two days.

2021-07-27

ok

抱歉，原内容已删除

2021-09-10

$TIGR 20210917 15.0 CALL(TIGR)$[呆住]

2021-10-09

ok

US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week

2021-09-04

ok

Tech lifts Nasdaq to record close but Wall Street mixed on jobs report

2021-08-05

ok

抱歉，原内容已删除

2021-09-15

$AMC 20210924 48.0 PUT(AMC)$guess why why I still holding?

2021-06-20

good

U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week

2021-09-10

$Tiger Brokers(TIGR)$my monthly commision is 1000 taken by tiger, tmr report cant be bad one. guys, we must wiong right now, tmr will be 20%

2021-08-20

$Tiger Brokers(TIGR)$能恢复20块吗？26号的财报

2021-10-08

ok

抱歉，原内容已删除

2021-09-10

$TIGR 20210917 15.0 CALL(TIGR)$Guys Guys, dont sell tiger now, holdd next monday will hit 20, a lot people dont believe can bounced back, but now is the best chance, china gdp is very high, now china market is a super good time to invest, buy to the moon if u trust me

2021-08-24

$ContextLogic Inc.(WISH)$based on 52weeks report we can see that price is $6.12, and now is just $6.70, its the best timing to buy more on this. Especially buy call option just for a few dayz!!!😏

2021-08-20

$Tiger Brokers(TIGR)$Let's think about Q1 RESULT, this company had worth more than 20, just hold until next week result, Q2 To Da mooonn[666] [666] [666] [666]

2021-07-22

k

China Evergrande says has solved legal disputes with Guangfa Bank

2021-08-20

$Tiger Brokers(TIGR)$ HOLD HOLD HOLD, next week Monday will Jump, till report is out. Look at this week had dropp whole week, every Monday will adjust one, just like last week's Monday go up, this week Monday go down. So we hold until next week Monday because report will out soon. To the moon[开心] [开心] [财迷] [财迷] [财迷] [财迷]

2021-07-16

ok

Cleveland Clinic, Mount Sinai and Providence Won’t Give Biogen’s New Alzheimer’s Drug

2021-07-01

k

S&P 500 notches fifth straight record closing high, fifth straight quarterly gain

2021-08-20

$Tiger Brokers(TIGR)$u might cry next week if u don't buy today

2021-08-20

$Tiger Brokers(TIGR)$大家知道几号会发财报

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3579215123116789","uuid":"3579215123116789","gmtCreate":1616121099368,"gmtModify":1636105431515,"name":"Steu","pinyin":"steu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":55,"headSize":506,"tweetSize":209,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.73%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":698532206,"gmtCreate":1640442516634,"gmtModify":1640442517244,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698532206","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","kind":"highlight","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","JNJ":"强生","BMY":"施贵宝"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698815114,"gmtCreate":1640337832912,"gmtModify":1640337833531,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698815114","repostId":"1141357068","repostType":4,"repost":{"id":"1141357068","kind":"news","pubTimestamp":1640337018,"share":"https://www.laohu8.com/m/news/1141357068?lang=&edition=full","pubTime":"2021-12-24 17:10","market":"us","language":"en","title":"3 Stocks to Buy While They Are on Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1141357068","media":"Motley Fool","summary":"The market has been particularly harsh to high-growth stocks over recent months, causing major price","content":"<p>The market has been particularly harsh to&nbsp;high-growth&nbsp;stocks&nbsp;over recent months, causing major price declines in otherwise solid companies. The omicron coronavirus variant, soaring inflation, and the possibility of interest rate hikes next year are all causing uncertainty for investors today.</p>\n<p>Opportunities to buy outstanding businesses at significant discounts to their recent highs are rare. Now is not the time to abandon your long-term investing strategy. Instead, take a look at the following stocks as potential additions to your portfolio right now.</p>\n<p><b>1. Etsy</b></p>\n<p>The first stock you should consider is online marketplace&nbsp;<b>Etsy</b>&nbsp;(NASDAQ:ETSY). It's down 26% in the past month as investors worry that the pandemic-induced surge in demand for its unique goods will fade with economies slowly reopening. But if we zoom out and focus on the bigger picture, Etsy is doing just fine.</p>\n<p>The platform generated $3.1 billion in gross merchandise sales (GMS) in the third quarter, up 17.9% over the year-ago period. This was all the more impressive given that a year ago GMS shot up 119%. The ecosystem is robust and growing with 96 million active buyers and 7.5 million active sellers, both of which are up substantially on a sequential basis.</p>\n<p>Over the past 12 months, Etsy's profit margin was a superb 21.6%. And the&nbsp;business is a cash cow, producing $584&nbsp;million in free cash flow during that time. That leaves lots of room to potentially buy back stock, further boosting earnings per share.</p>\n<p>The stock has been a massive outperformer, skyrocketing nearly 1,600%&nbsp;over the past five years. But don't think the party is over for this&nbsp;booming&nbsp;e-commerce&nbsp;business. CEO Josh Silverman has ambitions to create a \"House of Brands\" that will penetrate what the leadership team believes is a $1.7&nbsp;trillion global opportunity. The recent acquisitions of Depop, a secondhand-fashion reseller, and Elo7, known as the Etsy of Brazil, should help support that&nbsp;vision of growth for the company in the decade ahead.</p>\n<p><b>2. The Joint Corp.</b></p>\n<p>Who knew that offering fast and&nbsp;affordable back adjustments would be such a&nbsp;lucrative&nbsp;business model? That's exactly what&nbsp;<b>The Joint Corp.</b>&nbsp;(NASDAQ:JYNT)is doing. The nationwide franchisor and operator of&nbsp;666&nbsp;chiropractic clinics has been growing at a breathtaking pace. A decade ago, the company had just 26 locations.</p>\n<p>After reaching an all-time high of $107.30 in early September, the stock has crashed over 40%. Even so, the price is up 135% year to date. This company does away with the traditional, insurance-based structure by letting patients walk in (no appointment needed) and receive quick and effective treatment from a licensed chiropractor. At $29, a visit here is often lower than co-pays at independent chiropractor offices.</p>\n<p>The model is working. Same-store sales for locations open at least four years jumped 21%&nbsp;in the latest quarter. And with annual spending on back pain in the U.S. estimated to be $134 billion, there is a massive market opportunity. The Joint's trailing-12-month revenue totaled $75 million.</p>\n<p>Management is confident the company can one day have 1,800 locations in the U.S., almost triple its current footprint. With 295 clinics in active development and 132 franchise licenses sold in the first nine months of 2021, The Joint is well on its way to bringing chiropractic care to the masses.</p>\n<p><b>3. Roku</b></p>\n<p>Perhaps the biggest shocker on this list is&nbsp;<b>Roku</b>&nbsp;(NASDAQ:ROKU), which has seen its stock&nbsp;shed roughly half of its value&nbsp;since July. Some challenges, including missing Wall Street's sales estimates in the third quarter plus supply-chain bottlenecks, are certainly pressuring the stock. But I still firmly believe that the long-term outlook for Roku is intact.</p>\n<p>This top streaming business is attractive not because of its media sticks, which have actually been sold at a loss in the past two quarters, but because of its burgeoning platform segment. This is where high-margin advertising and subscription fees are. In the most recent quarter, the platform business represented 86%&nbsp;of total revenue, a figure that has steadily increased over time.</p>\n<p>Roku's 56.4&nbsp;million active accounts streamed 18 billion hours of content in the latest three-month period. But what really stood out was the average revenue per user of $40.10. The monster success of The Roku Channel, now a top-five channel on the platform, has further helped ad revenue. This allows even greater investment in content (including 50 new original series planned over the next two years), bringing in new viewers.</p>\n<p>The management team, led by CEO Anthony Wood, thinks that streaming is the future of video entertainment. The ongoing decline of cable-TV subscribers makes this trend undeniable. Roku will continue riding this wave as it tackles overseas markets, particularly in Europe and Latin America.</p>\n<p>Taking advantage of what the market is giving you today by adding shares in these proven winners, now at steep discounts, could be a game-changer for your portfolio.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy While They Are on Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy While They Are on Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/23/3-stocks-to-buy-while-they-are-on-sale/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The market has been particularly harsh to high-growth stocks over recent months, causing major price declines in otherwise solid companies. The omicron coronavirus variant, soaring inflation, and the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/23/3-stocks-to-buy-while-they-are-on-sale/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc.","JYNT":"The Joint Corp.","ROKU":"Roku Inc"},"source_url":"https://www.fool.com/investing/2021/12/23/3-stocks-to-buy-while-they-are-on-sale/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141357068","content_text":"The market has been particularly harsh to high-growth stocks over recent months, causing major price declines in otherwise solid companies. The omicron coronavirus variant, soaring inflation, and the possibility of interest rate hikes next year are all causing uncertainty for investors today.\nOpportunities to buy outstanding businesses at significant discounts to their recent highs are rare. Now is not the time to abandon your long-term investing strategy. Instead, take a look at the following stocks as potential additions to your portfolio right now.\n1. Etsy\nThe first stock you should consider is online marketplace Etsy (NASDAQ:ETSY). It's down 26% in the past month as investors worry that the pandemic-induced surge in demand for its unique goods will fade with economies slowly reopening. But if we zoom out and focus on the bigger picture, Etsy is doing just fine.\nThe platform generated $3.1 billion in gross merchandise sales (GMS) in the third quarter, up 17.9% over the year-ago period. This was all the more impressive given that a year ago GMS shot up 119%. The ecosystem is robust and growing with 96 million active buyers and 7.5 million active sellers, both of which are up substantially on a sequential basis.\nOver the past 12 months, Etsy's profit margin was a superb 21.6%. And the business is a cash cow, producing $584 million in free cash flow during that time. That leaves lots of room to potentially buy back stock, further boosting earnings per share.\nThe stock has been a massive outperformer, skyrocketing nearly 1,600% over the past five years. But don't think the party is over for this booming e-commerce business. CEO Josh Silverman has ambitions to create a \"House of Brands\" that will penetrate what the leadership team believes is a $1.7 trillion global opportunity. The recent acquisitions of Depop, a secondhand-fashion reseller, and Elo7, known as the Etsy of Brazil, should help support that vision of growth for the company in the decade ahead.\n2. The Joint Corp.\nWho knew that offering fast and affordable back adjustments would be such a lucrative business model? That's exactly what The Joint Corp. (NASDAQ:JYNT)is doing. The nationwide franchisor and operator of 666 chiropractic clinics has been growing at a breathtaking pace. A decade ago, the company had just 26 locations.\nAfter reaching an all-time high of $107.30 in early September, the stock has crashed over 40%. Even so, the price is up 135% year to date. This company does away with the traditional, insurance-based structure by letting patients walk in (no appointment needed) and receive quick and effective treatment from a licensed chiropractor. At $29, a visit here is often lower than co-pays at independent chiropractor offices.\nThe model is working. Same-store sales for locations open at least four years jumped 21% in the latest quarter. And with annual spending on back pain in the U.S. estimated to be $134 billion, there is a massive market opportunity. The Joint's trailing-12-month revenue totaled $75 million.\nManagement is confident the company can one day have 1,800 locations in the U.S., almost triple its current footprint. With 295 clinics in active development and 132 franchise licenses sold in the first nine months of 2021, The Joint is well on its way to bringing chiropractic care to the masses.\n3. Roku\nPerhaps the biggest shocker on this list is Roku (NASDAQ:ROKU), which has seen its stock shed roughly half of its value since July. Some challenges, including missing Wall Street's sales estimates in the third quarter plus supply-chain bottlenecks, are certainly pressuring the stock. But I still firmly believe that the long-term outlook for Roku is intact.\nThis top streaming business is attractive not because of its media sticks, which have actually been sold at a loss in the past two quarters, but because of its burgeoning platform segment. This is where high-margin advertising and subscription fees are. In the most recent quarter, the platform business represented 86% of total revenue, a figure that has steadily increased over time.\nRoku's 56.4 million active accounts streamed 18 billion hours of content in the latest three-month period. But what really stood out was the average revenue per user of $40.10. The monster success of The Roku Channel, now a top-five channel on the platform, has further helped ad revenue. This allows even greater investment in content (including 50 new original series planned over the next two years), bringing in new viewers.\nThe management team, led by CEO Anthony Wood, thinks that streaming is the future of video entertainment. The ongoing decline of cable-TV subscribers makes this trend undeniable. Roku will continue riding this wave as it tackles overseas markets, particularly in Europe and Latin America.\nTaking advantage of what the market is giving you today by adding shares in these proven winners, now at steep discounts, could be a game-changer for your portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":951,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871569404,"gmtCreate":1637085980917,"gmtModify":1637086338526,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"title":"Tiger broker got problem?","htmlText":"why my apps&nbsp;cannot see the watchlist? anyone faced this issue now?","listText":"why my apps&nbsp;cannot see the watchlist? anyone faced this issue now?","text":"why my apps cannot see the watchlist? anyone faced this issue now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871569404","isVote":1,"tweetType":1,"viewCount":1153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879660753,"gmtCreate":1636718017672,"gmtModify":1636718017940,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok//<a href=\"https://laohu8.com/U/3579215123116789\">@Steu</a>:will this tesla go dip?","listText":"ok//<a href=\"https://laohu8.com/U/3579215123116789\">@Steu</a>:will this tesla go dip?","text":"ok//@Steu:will this tesla go dip?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879660753","repostId":"1101762629","repostType":2,"isVote":1,"tweetType":1,"viewCount":722,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879685881,"gmtCreate":1636717427229,"gmtModify":1636717460842,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"will this tesla go dip?","listText":"will this tesla go dip?","text":"will this tesla go dip?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879685881","repostId":"1101762629","repostType":2,"repost":{"id":"1101762629","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636715542,"share":"https://www.laohu8.com/m/news/1101762629?lang=&edition=full","pubTime":"2021-11-12 19:12","market":"us","language":"en","title":"Musk further sold Tesla shares on November 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1101762629","media":"Tiger Newspress","summary":"Musk further sold Tesla shares on November 11, according to the SEC files.","content":"<p>Musk further sold Tesla shares on November 11,&nbsp;according to the SEC files.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk further sold Tesla shares on November 11</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk further sold Tesla shares on November 11\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 19:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Musk further sold Tesla shares on November 11,&nbsp;according to the SEC files.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101762629","content_text":"Musk further sold Tesla shares on November 11, according to the SEC files.","news_type":1},"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842309949,"gmtCreate":1636129157276,"gmtModify":1636129158129,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"nice job. beats&nbsp;","listText":"nice job. beats&nbsp;","text":"nice job. beats","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842309949","repostId":"1163952473","repostType":2,"repost":{"id":"1163952473","kind":"news","pubTimestamp":1636125589,"share":"https://www.laohu8.com/m/news/1163952473?lang=&edition=full","pubTime":"2021-11-05 23:19","market":"us","language":"en","title":"Amazon Seeks Another 4,538 Satellites to Challenge Musk’s SpaceX","url":"https://stock-news.laohu8.com/highlight/detail?id=1163952473","media":"Bloomberg","summary":"Amazon’s Kuiper fleet would grow to 7,774 satellites\nKuiper and SpaceX have sparred at the FCC over ","content":"<ul>\n <li>Amazon’s Kuiper fleet would grow to 7,774 satellites</li>\n <li>Kuiper and SpaceX have sparred at the FCC over applications</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0a861ad1262b0fb53f4a72e6d237181d\" tg-width=\"2097\" tg-height=\"1398\" width=\"100%\" height=\"auto\"><span>Artist render of the ABL Space Systems' new RS1 rocket, which will launch Amazon’s Project Kuiper satellites. Source: Amazon.com Inc.</span></p>\n<p>Amazon.com Inc.’s Kuiper Systems LLC asked U.S. regulators for permission to launch another 4,538 satellites that would bolster its constellation as it competes with Elon Musk’s SpaceX for broadband-from-space customers.</p>\n<p>The additions would bring Kuiper’s constellation to 7,774 satellites, the company said in&nbsp;a filing&nbsp;Thursday with the Federal Communications Commission.</p>\n<p>Kuiper and Musk’s Space Exploration Technologies Corp. each have applications before the FCC for satellite fleets in low-earth orbit. The companies have been sparring in recent months, with Amazon&nbsp;contending&nbsp;that SpaceX hasn’t met regulatory requirements. SpaceX dismissed the criticism as irrelevant.</p>\n<p>SpaceX has emerged as a space leader, having launched at least 1,700 of its&nbsp;Starlink&nbsp;broadband satellites with plans for thousands more. Amazon.com earlier won FCC approval for 3,236 satellites, and says it&nbsp;will launch&nbsp;two prototypes late next year. London-based&nbsp;OneWeb&nbsp;is building a fleet of 648 satellites. The&nbsp;Boeing Co.&nbsp;on Nov. 3 won permission from the FCC for a fleet of 147 communications satellites.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon Seeks Another 4,538 Satellites to Challenge Musk’s SpaceX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon Seeks Another 4,538 Satellites to Challenge Musk’s SpaceX\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 23:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-05/amazon-seeks-to-add-4-538-satellites-to-challenge-musk-s-spacex?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon’s Kuiper fleet would grow to 7,774 satellites\nKuiper and SpaceX have sparred at the FCC over applications\n\nArtist render of the ABL Space Systems' new RS1 rocket, which will launch Amazon’s ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-05/amazon-seeks-to-add-4-538-satellites-to-challenge-musk-s-spacex?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-05/amazon-seeks-to-add-4-538-satellites-to-challenge-musk-s-spacex?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163952473","content_text":"Amazon’s Kuiper fleet would grow to 7,774 satellites\nKuiper and SpaceX have sparred at the FCC over applications\n\nArtist render of the ABL Space Systems' new RS1 rocket, which will launch Amazon’s Project Kuiper satellites. Source: Amazon.com Inc.\nAmazon.com Inc.’s Kuiper Systems LLC asked U.S. regulators for permission to launch another 4,538 satellites that would bolster its constellation as it competes with Elon Musk’s SpaceX for broadband-from-space customers.\nThe additions would bring Kuiper’s constellation to 7,774 satellites, the company said in a filing Thursday with the Federal Communications Commission.\nKuiper and Musk’s Space Exploration Technologies Corp. each have applications before the FCC for satellite fleets in low-earth orbit. The companies have been sparring in recent months, with Amazon contending that SpaceX hasn’t met regulatory requirements. SpaceX dismissed the criticism as irrelevant.\nSpaceX has emerged as a space leader, having launched at least 1,700 of its Starlink broadband satellites with plans for thousands more. Amazon.com earlier won FCC approval for 3,236 satellites, and says it will launch two prototypes late next year. London-based OneWeb is building a fleet of 648 satellites. The Boeing Co. on Nov. 3 won permission from the FCC for a fleet of 147 communications satellites.","news_type":1},"isVote":1,"tweetType":1,"viewCount":748,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843867751,"gmtCreate":1635818343709,"gmtModify":1635818343966,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"like urself","listText":"like urself","text":"like urself","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843867751","repostId":"1129056623","repostType":4,"repost":{"id":"1129056623","kind":"news","pubTimestamp":1635817478,"share":"https://www.laohu8.com/m/news/1129056623?lang=&edition=full","pubTime":"2021-11-02 09:44","market":"us","language":"en","title":"Electric vehicle maker Rivian seeks to raise $8.4 billion in IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1129056623","media":"TechCrunch","summary":"Electric vehicle startup Rivian hopes to raise up $8.4 billion in its initial public offering, accor","content":"<p>Electric vehicle startup Rivian hopes to raise up $8.4 billion in its initial public offering, according to aregulatory filing&nbsp;posted Monday.</p>\n<p>The company, which is backed by Amazon, said in the filing that it plans to offer 135 million shares at a price between $57 and $62. Underwriters also have an option to buy up to 20.25 million additional shares. If underwriters exercise that option, Rivian would raise as much as $9.6 billion.</p>\n<p>Based on the number of outstanding shares, that would put its market valuation at about $53 billion. If employee stock options and other restricted shares are considered, Rivian's valuation could be as high as $60 billion.</p>\n<p>Rivian filed October 1 to become a&nbsp;publicly traded company&nbsp;in the United States. The S-1 document did not disclose the targeted share price at the time. An amended document filed Monday provided the new information, which included interest from repeat backer Amazon and newcomer Blackstone in Rivian.</p>\n<p>Amazon, funds and accounts advised by T. Rowe Price Associates, Coatue Management, Franklin Templeton, Capital Research Global Investors, D1 Capital Partners LP, Third Point LLC, funds affiliated with Blackstone Alternative Asset Management, Dragoneer Investment Group LLC and certain entities affiliated with Soros Fund Management LLC have indicated an interest in buying up to $5 billion of shares of Class A common stock.</p>\n<p>A recent filing by Amazon shows the e-commerce giant already holds a&nbsp;20% stake in Rivian.</p>\n<p>Rivian's filing was been one of the most anticipated of the year; now attention has turned to its public debut on the Nasdaq exchange. Rivian will trade under the ticker symbol RIVN.</p>","source":"lsy1602557183277","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electric vehicle maker Rivian seeks to raise $8.4 billion in IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectric vehicle maker Rivian seeks to raise $8.4 billion in IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-02 09:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/electric-vehicle-maker-rivian-seeks-231423387.html><strong>TechCrunch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric vehicle startup Rivian hopes to raise up $8.4 billion in its initial public offering, according to aregulatory filing posted Monday.\nThe company, which is backed by Amazon, said in the filing...</p>\n\n<a href=\"https://finance.yahoo.com/news/electric-vehicle-maker-rivian-seeks-231423387.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","AMZN":"亚马逊"},"source_url":"https://finance.yahoo.com/news/electric-vehicle-maker-rivian-seeks-231423387.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129056623","content_text":"Electric vehicle startup Rivian hopes to raise up $8.4 billion in its initial public offering, according to aregulatory filing posted Monday.\nThe company, which is backed by Amazon, said in the filing that it plans to offer 135 million shares at a price between $57 and $62. Underwriters also have an option to buy up to 20.25 million additional shares. If underwriters exercise that option, Rivian would raise as much as $9.6 billion.\nBased on the number of outstanding shares, that would put its market valuation at about $53 billion. If employee stock options and other restricted shares are considered, Rivian's valuation could be as high as $60 billion.\nRivian filed October 1 to become a publicly traded company in the United States. The S-1 document did not disclose the targeted share price at the time. An amended document filed Monday provided the new information, which included interest from repeat backer Amazon and newcomer Blackstone in Rivian.\nAmazon, funds and accounts advised by T. Rowe Price Associates, Coatue Management, Franklin Templeton, Capital Research Global Investors, D1 Capital Partners LP, Third Point LLC, funds affiliated with Blackstone Alternative Asset Management, Dragoneer Investment Group LLC and certain entities affiliated with Soros Fund Management LLC have indicated an interest in buying up to $5 billion of shares of Class A common stock.\nA recent filing by Amazon shows the e-commerce giant already holds a 20% stake in Rivian.\nRivian's filing was been one of the most anticipated of the year; now attention has turned to its public debut on the Nasdaq exchange. Rivian will trade under the ticker symbol RIVN.","news_type":1},"isVote":1,"tweetType":1,"viewCount":817,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849097991,"gmtCreate":1635698284458,"gmtModify":1635698284735,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"hehw","listText":"hehw","text":"hehw","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849097991","repostId":"2179471352","repostType":4,"repost":{"id":"2179471352","kind":"highlight","pubTimestamp":1635566092,"share":"https://www.laohu8.com/m/news/2179471352?lang=&edition=full","pubTime":"2021-10-30 11:54","market":"hk","language":"en","title":"Opinion:Here's the math for Tesla's stock price if it becomes the Apple of car makers","url":"https://stock-news.laohu8.com/highlight/detail?id=2179471352","media":"Market watch","summary":"For those that don’t know, in the early 2000s it was unimaginable that these legacy mobile phone manufacturers could disappear. In 2006, Research in Motion , the company making BlackBerrys, lost a patent suit against NTP and a U.S. District Court judge slapped an injunction on sales. The Defense Department stepped in, claiming that a Blackberry injunction was a threat to national security. Meanwhile, industry leader Nokia held a 40% market share and by the end of 2007 sported a $230 billion mark","content":"<p>Fans and shareholders of Tesla are making stronger and louder arguments about the future of their favorite company. In them, they draw analogies to one of the most successful brands and businesses in the history of capitalism. They suggest that automaking may go the way of handset manufacturing and that – for TeslaTSLA,+3.43%– there is a strong resemblance to the AppleAAPL,-1.82%vs. Nokia/Blackberry/Ericsson/Motorola dynamic.</p>\n<p>For those that don’t know, in the early 2000s it was unimaginable that these legacy mobile phone manufacturers could disappear. In 2006, Research in Motion (RIM), the company making BlackBerrys, lost a patent suit against NTP and a U.S. District Court judge slapped an injunction on sales. The Defense Department stepped in, claiming that a Blackberry injunction was a threat to national security. Meanwhile, industry leader Nokia held a 40% market share and by the end of 2007 sported a $230 billion market cap.</p>\n<p>But something else happened in 2007.</p>\n<p>Steve Jobs introduced the iPhone.</p>\n<p>And that changed the game for Nokia, Blackberry and the entire industry, forever.</p>\n<p>Coincidentally, Jobs introduced that iPhone seven months after Tesla introduced the Roadster at the San Francisco International Auto Show. Fast forward to 2021, and the bulls are suggesting that Apple’s overwhelming success in handset manufacturing can be mirrored in automobile manufacturing by Elon Musk’s Tesla.</p>\n<p>For this to happen, let’s first assume that within 15 years buyers will demand a broadly similar “form factor” for any vehicle. Today, there are 250 brands of cars sold to fit all appetites and budgets, and perhaps over 1,000 trims. Meanwhile, thanks to the iPhone, handset hardware has gone from a myriad of styles, sizes and forms to basically one.</p>\n<p>Similarly, let’s imagine that the production and value of automobiles and light trucks will become less about the style or performance that is demanded and instead mostly about the software inside the vehicle.</p>\n<p>Finally (and this is a huge debate, but) let’s presuppose that Tesla will have better software – most importantly better autonomous driving capability – than any other vendor or manufacturer, whether in Silicon Valley, Detroit, Wolfsburg or elsewhere.</p>\n<p>In other words, let’s assume that Tesla is going to become the Apple of automakers.</p>\n<p>To do this, we need to ignore that Apple is not just a handset manufacturer. In the first three quarters this year, it reported over $150 billion of iPhone sales, which represented 55% of total sales. It also reported sales from the “Services” segment, which included sales from advertising, digital content, AppleCare and other lines. If we assume all that revenue was driven by the iPhone (even though not all was), then we get the iPhone representing about 65%-70% of Apple’s sales.</p>\n<p>This implies Apple has a substantial business (about $110 billion this year) selling Macs, iPads, wearables and accessories too. So in our “Tesla is Apple” analogy, we need to assume that Tesla will make similar extensions into new products.</p>\n<p>We also need to ignore that most of the profit for Apple in handsets comes from mobile advertising and app sales, much of which Apple reports in that services segment noted above. Again, to stay in our framework, we also need to believe that Tesla would generate something similar via its over-the-air updates or its own app store.</p>\n<p>Making all these assumptions, then future margins in “automaking” – for at least one manufacturer – could theoretically start trending up toward the margins generated today by Apple.</p>\n<p>So in terms of handset market share, people around the world are going to buy approximately 1.4 billion handsets this year, and the average selling price will be about $320. Apple has about 16% of the global market, and will sell about 225 million iPhones.</p>\n<p>Just guessing here, but if these iPhones are sold at an average price of $890, then the average price of all the other phones sold in the world needs to be about $125 for the math to make sense. And because Apple can sell its iPhone at such a huge premium and produce remarkable revenues from advertising and app store sales, it generates a whopping 24% earnings margin.</p>\n<p>In comparison, VolkswagenVOW3,-0.49%VWAPY,-2.43%,which started operations in 1938, has worked its way up to a global market share of 12.0% and generates net income margins of 5.0%.</p>\n<p>Toyota7203,+0.33%TM,+0.05%,which also started operations in 1938, also has a global market share of 12.0% and generates even better net income margins of approximately 7.0%.</p>\n<p>Nokia, for what it is worth, generated 14% net margins before the iPhone changed the game.&nbsp; In other words, even before Apple showed up, handset manufacturing was over twice as profitable for market leaders as making cars.</p>\n<p>Anyway, folks around the world will buy about 75 million new cars this year, and at an average price of $30,000 (ballpark) this works out to over $2.2 trillion in sales. This is about five times larger than the handset market, which will come in at about $450 million. Toyota and Volkswagen are the largest – and best in class – scale automobile manufacturers in the world. Other groups, including FordF,+1.30%,Stellantis (FCA/Peugeot)STLA,-0.50%,DaimlerDAI,+2.25%,General MotorsGM,+0.35%,Honda7267,-0.53%HMC,-0.40%,BMWBMW,-0.11%and many others also have significant share.</p>\n<p>This year, Tesla will sell about a million cars, representing a global market share of 1.3%.</p>\n<p>And dare I say that each of Tesla’s competitors will be loath to surrender more market share, thus the huge amount of R&amp;D and capital spending they will devote to the upcoming transition to electric vehicles (EVs). On the CAPEX metric alone, we can see that these competitors will actually spend more next year than Tesla.</p>\n<p>A lot more.</p>\n<p><img src=\"https://static.tigerbbs.com/c0b0383d691f139a5d04a2a94c2bd399\" tg-width=\"699\" tg-height=\"481\" referrerpolicy=\"no-referrer\">ALBERT BRIDGE CAPITAL</p>\n<p>But still, let’s assume all the legacy automakers fail to maintain share. Let’s also envision that most of the profits in the industry will eventually go to Tesla (as they have in handsets to Apple).</p>\n<p>As a baseline, analysts anticipate that Tesla will generate over $50 billion in sales this year. Over 85% of these sales are related to its automotive business.</p>\n<p>In 2035, if EVs represents 95% of all new cars sold, and Tesla has the same 16% market share as Apple does today (significantly eclipsing that of VW or Toyota), it will be producing 22 million cars and light trucks, and generating sales of over $1 trillion.</p>\n<p>This year, analysts anticipate that Tesla will generate nearly $7 billion in adjusted net income (which will include approximately $1.2 billion in profits driven by regulatory credits).</p>\n<p>If Tesla were able to generate the same 24% net earnings margin as Apple does today (remember VW is at 5% and Toyota at 7%), then it would produce about $250 billion of earnings in 2035.</p>\n<p>As Tesla has grown from zero to one million cars, it has built production facilities in Freemont, Shanghai and soon Austin; battery-producing gigafactories in Nevada, Buffalo, Germany and Austin again; and other manufacturing and tooling facilities in Michigan, Ontario, Shanghai, two more in California and three more in Germany.</p>\n<p>To finance this expansion, Tesla went from 35 million diluted shares in 2009 to 641 million in 2015 to over 1.1 billion today. Of course some of these went to key executives in the firm as compensation, but for the most part, this share issuance helped to finance the firm’s stunning growth to date.</p>\n<p>And if Tesla is going to build over 20 million units a year (up from about 1 million this year), this will require a lot more capital. But given its strong share price and internal cash flow generation, let’s assume that the rate of new share issuance at Tesla will slow dramatically, to just 1.5% new shares per year. At this rate, they would have “only” 1.4 billion shares in 2035.</p>\n<p>And in that year, on production of 22 million vehicles at an average selling price of $46,000 (again, our guess) and doing 24% net earnings margins, this $250 billion of earnings would work out to about $178 per share.</p>\n<p>Given Tesla’s domination in this scenario where it maxes out its market share, the only negative is that it would no longer be a secular story, but one more exposed to the cyclical nature of automaking. So its huge amount of revenue and income would naturally be growing much more slowly by then. But, again for the sake of this exercise, let’s assume that Tesla will still find a way to continue to generate a consistent 10% EPS growth on that $250 billion number.</p>\n<p>And despite this slowing, let’s also assume that investors will want to pay a P/E ratio of over 20 for a now huge and cyclical business.</p>\n<p>On a P/E of 22.5, that would work out to a market cap of $5.6 trillion, and a share price of $4,000.</p>\n<p>These are big numbers. And despite what we hear from the more optimistic of the Tesla bulls, let’s also assume that today’s shareholders only hope to make 10% per year between now and 2035.</p>\n<p>If we discount that $4,000 by 10% back to today, the shares are worth $1,050.</p>\n<p>That is pretty close to where we are right now.</p>\n<p>So all that above is what needs to happen for $1,050 to be a fair share price today.</p>\n<p>Doubters, admittedly like us, will suggest that the execution risk is tremendous, and these market shares (and particularly the margins) may be impossible.</p>\n<p>Yet, despite the fact that we actually can’t ignore the differences between the mobile phone and automobile industries noted above, the believers – who may indeed be right – will literally need to see Apple-esque industry dynamics, market shares and earnings margins for this all to make sense.</p>\n<p>It is also important to consider that for there to be even more upside in the shares from current levels, Tesla will actually have to exceed everything that Apple has accomplished.</p>\n<p>Whether a bull or a bear, there is no doubting that what Musk has achieved thus far has been nothing short of incredible. Five years ago, few would have thought it even possible that Hertz would order 100,000 Teslas in a single order for its car rental fleet, or that Tesla would produce and sell a million cars in a single year.</p>\n<p>He will continue to do incredible things.&nbsp; He has changed the world and the mindset of his competitors. None of that is in question. The future that his share price is discounting is the question we are asking today.</p>","source":"lsy1616996754749","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion:Here's the math for Tesla's stock price if it becomes the Apple of car makers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion:Here's the math for Tesla's stock price if it becomes the Apple of car makers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-30 11:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/if-tesla-is-to-become-the-apple-of-car-makers-this-is-what-it-means-for-the-stock-price-and-the-business-11635513589?mod=home-page><strong>Market watch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fans and shareholders of Tesla are making stronger and louder arguments about the future of their favorite company. In them, they draw analogies to one of the most successful brands and businesses in ...</p>\n\n<a href=\"https://www.marketwatch.com/story/if-tesla-is-to-become-the-apple-of-car-makers-this-is-what-it-means-for-the-stock-price-and-the-business-11635513589?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.marketwatch.com/story/if-tesla-is-to-become-the-apple-of-car-makers-this-is-what-it-means-for-the-stock-price-and-the-business-11635513589?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179471352","content_text":"Fans and shareholders of Tesla are making stronger and louder arguments about the future of their favorite company. In them, they draw analogies to one of the most successful brands and businesses in the history of capitalism. They suggest that automaking may go the way of handset manufacturing and that – for TeslaTSLA,+3.43%– there is a strong resemblance to the AppleAAPL,-1.82%vs. Nokia/Blackberry/Ericsson/Motorola dynamic.\nFor those that don’t know, in the early 2000s it was unimaginable that these legacy mobile phone manufacturers could disappear. In 2006, Research in Motion (RIM), the company making BlackBerrys, lost a patent suit against NTP and a U.S. District Court judge slapped an injunction on sales. The Defense Department stepped in, claiming that a Blackberry injunction was a threat to national security. Meanwhile, industry leader Nokia held a 40% market share and by the end of 2007 sported a $230 billion market cap.\nBut something else happened in 2007.\nSteve Jobs introduced the iPhone.\nAnd that changed the game for Nokia, Blackberry and the entire industry, forever.\nCoincidentally, Jobs introduced that iPhone seven months after Tesla introduced the Roadster at the San Francisco International Auto Show. Fast forward to 2021, and the bulls are suggesting that Apple’s overwhelming success in handset manufacturing can be mirrored in automobile manufacturing by Elon Musk’s Tesla.\nFor this to happen, let’s first assume that within 15 years buyers will demand a broadly similar “form factor” for any vehicle. Today, there are 250 brands of cars sold to fit all appetites and budgets, and perhaps over 1,000 trims. Meanwhile, thanks to the iPhone, handset hardware has gone from a myriad of styles, sizes and forms to basically one.\nSimilarly, let’s imagine that the production and value of automobiles and light trucks will become less about the style or performance that is demanded and instead mostly about the software inside the vehicle.\nFinally (and this is a huge debate, but) let’s presuppose that Tesla will have better software – most importantly better autonomous driving capability – than any other vendor or manufacturer, whether in Silicon Valley, Detroit, Wolfsburg or elsewhere.\nIn other words, let’s assume that Tesla is going to become the Apple of automakers.\nTo do this, we need to ignore that Apple is not just a handset manufacturer. In the first three quarters this year, it reported over $150 billion of iPhone sales, which represented 55% of total sales. It also reported sales from the “Services” segment, which included sales from advertising, digital content, AppleCare and other lines. If we assume all that revenue was driven by the iPhone (even though not all was), then we get the iPhone representing about 65%-70% of Apple’s sales.\nThis implies Apple has a substantial business (about $110 billion this year) selling Macs, iPads, wearables and accessories too. So in our “Tesla is Apple” analogy, we need to assume that Tesla will make similar extensions into new products.\nWe also need to ignore that most of the profit for Apple in handsets comes from mobile advertising and app sales, much of which Apple reports in that services segment noted above. Again, to stay in our framework, we also need to believe that Tesla would generate something similar via its over-the-air updates or its own app store.\nMaking all these assumptions, then future margins in “automaking” – for at least one manufacturer – could theoretically start trending up toward the margins generated today by Apple.\nSo in terms of handset market share, people around the world are going to buy approximately 1.4 billion handsets this year, and the average selling price will be about $320. Apple has about 16% of the global market, and will sell about 225 million iPhones.\nJust guessing here, but if these iPhones are sold at an average price of $890, then the average price of all the other phones sold in the world needs to be about $125 for the math to make sense. And because Apple can sell its iPhone at such a huge premium and produce remarkable revenues from advertising and app store sales, it generates a whopping 24% earnings margin.\nIn comparison, VolkswagenVOW3,-0.49%VWAPY,-2.43%,which started operations in 1938, has worked its way up to a global market share of 12.0% and generates net income margins of 5.0%.\nToyota7203,+0.33%TM,+0.05%,which also started operations in 1938, also has a global market share of 12.0% and generates even better net income margins of approximately 7.0%.\nNokia, for what it is worth, generated 14% net margins before the iPhone changed the game.  In other words, even before Apple showed up, handset manufacturing was over twice as profitable for market leaders as making cars.\nAnyway, folks around the world will buy about 75 million new cars this year, and at an average price of $30,000 (ballpark) this works out to over $2.2 trillion in sales. This is about five times larger than the handset market, which will come in at about $450 million. Toyota and Volkswagen are the largest – and best in class – scale automobile manufacturers in the world. Other groups, including FordF,+1.30%,Stellantis (FCA/Peugeot)STLA,-0.50%,DaimlerDAI,+2.25%,General MotorsGM,+0.35%,Honda7267,-0.53%HMC,-0.40%,BMWBMW,-0.11%and many others also have significant share.\nThis year, Tesla will sell about a million cars, representing a global market share of 1.3%.\nAnd dare I say that each of Tesla’s competitors will be loath to surrender more market share, thus the huge amount of R&D and capital spending they will devote to the upcoming transition to electric vehicles (EVs). On the CAPEX metric alone, we can see that these competitors will actually spend more next year than Tesla.\nA lot more.\nALBERT BRIDGE CAPITAL\nBut still, let’s assume all the legacy automakers fail to maintain share. Let’s also envision that most of the profits in the industry will eventually go to Tesla (as they have in handsets to Apple).\nAs a baseline, analysts anticipate that Tesla will generate over $50 billion in sales this year. Over 85% of these sales are related to its automotive business.\nIn 2035, if EVs represents 95% of all new cars sold, and Tesla has the same 16% market share as Apple does today (significantly eclipsing that of VW or Toyota), it will be producing 22 million cars and light trucks, and generating sales of over $1 trillion.\nThis year, analysts anticipate that Tesla will generate nearly $7 billion in adjusted net income (which will include approximately $1.2 billion in profits driven by regulatory credits).\nIf Tesla were able to generate the same 24% net earnings margin as Apple does today (remember VW is at 5% and Toyota at 7%), then it would produce about $250 billion of earnings in 2035.\nAs Tesla has grown from zero to one million cars, it has built production facilities in Freemont, Shanghai and soon Austin; battery-producing gigafactories in Nevada, Buffalo, Germany and Austin again; and other manufacturing and tooling facilities in Michigan, Ontario, Shanghai, two more in California and three more in Germany.\nTo finance this expansion, Tesla went from 35 million diluted shares in 2009 to 641 million in 2015 to over 1.1 billion today. Of course some of these went to key executives in the firm as compensation, but for the most part, this share issuance helped to finance the firm’s stunning growth to date.\nAnd if Tesla is going to build over 20 million units a year (up from about 1 million this year), this will require a lot more capital. But given its strong share price and internal cash flow generation, let’s assume that the rate of new share issuance at Tesla will slow dramatically, to just 1.5% new shares per year. At this rate, they would have “only” 1.4 billion shares in 2035.\nAnd in that year, on production of 22 million vehicles at an average selling price of $46,000 (again, our guess) and doing 24% net earnings margins, this $250 billion of earnings would work out to about $178 per share.\nGiven Tesla’s domination in this scenario where it maxes out its market share, the only negative is that it would no longer be a secular story, but one more exposed to the cyclical nature of automaking. So its huge amount of revenue and income would naturally be growing much more slowly by then. But, again for the sake of this exercise, let’s assume that Tesla will still find a way to continue to generate a consistent 10% EPS growth on that $250 billion number.\nAnd despite this slowing, let’s also assume that investors will want to pay a P/E ratio of over 20 for a now huge and cyclical business.\nOn a P/E of 22.5, that would work out to a market cap of $5.6 trillion, and a share price of $4,000.\nThese are big numbers. And despite what we hear from the more optimistic of the Tesla bulls, let’s also assume that today’s shareholders only hope to make 10% per year between now and 2035.\nIf we discount that $4,000 by 10% back to today, the shares are worth $1,050.\nThat is pretty close to where we are right now.\nSo all that above is what needs to happen for $1,050 to be a fair share price today.\nDoubters, admittedly like us, will suggest that the execution risk is tremendous, and these market shares (and particularly the margins) may be impossible.\nYet, despite the fact that we actually can’t ignore the differences between the mobile phone and automobile industries noted above, the believers – who may indeed be right – will literally need to see Apple-esque industry dynamics, market shares and earnings margins for this all to make sense.\nIt is also important to consider that for there to be even more upside in the shares from current levels, Tesla will actually have to exceed everything that Apple has accomplished.\nWhether a bull or a bear, there is no doubting that what Musk has achieved thus far has been nothing short of incredible. Five years ago, few would have thought it even possible that Hertz would order 100,000 Teslas in a single order for its car rental fleet, or that Tesla would produce and sell a million cars in a single year.\nHe will continue to do incredible things.  He has changed the world and the mindset of his competitors. None of that is in question. The future that his share price is discounting is the question we are asking today.","news_type":1},"isVote":1,"tweetType":1,"viewCount":715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855339785,"gmtCreate":1635334052850,"gmtModify":1635334053090,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855339785","repostId":"1102358032","repostType":4,"repost":{"id":"1102358032","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635333593,"share":"https://www.laohu8.com/m/news/1102358032?lang=&edition=full","pubTime":"2021-10-27 19:19","market":"us","language":"en","title":"Kraft Heinz rose nearly 1% in premarket trading as it beat revenue estimates helped by higher prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1102358032","media":"Tiger Newspress","summary":"Kraft Heinz Co(KHC.O)beat Wall Street expectations for quarterly sales on Wednesday, as the packaged","content":"<p>Kraft Heinz Co(KHC.O)beat Wall Street expectations for quarterly sales on Wednesday, as the packaged food company benefited from raising product prices to tackle rising inflation.</p>\n<p>Net sales in the third quarter fell to $6.32 billion for the Jell-O maker from $6.44 billion a year earlier. Analysts on average had expected sales of $6.05 billion, according to Refinitiv IBES.</p>\n<p>Kraft Heinz Co&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;1%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3f1bab565eedd1970bcdb9f46852a165\" tg-width=\"780\" tg-height=\"560\" width=\"100%\" height=\"auto\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kraft Heinz rose nearly 1% in premarket trading as it beat revenue estimates helped by higher prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKraft Heinz rose nearly 1% in premarket trading as it beat revenue estimates helped by higher prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-27 19:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kraft Heinz Co(KHC.O)beat Wall Street expectations for quarterly sales on Wednesday, as the packaged food company benefited from raising product prices to tackle rising inflation.</p>\n<p>Net sales in the third quarter fell to $6.32 billion for the Jell-O maker from $6.44 billion a year earlier. Analysts on average had expected sales of $6.05 billion, according to Refinitiv IBES.</p>\n<p>Kraft Heinz Co&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;1%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3f1bab565eedd1970bcdb9f46852a165\" tg-width=\"780\" tg-height=\"560\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KHC":"卡夫亨氏"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102358032","content_text":"Kraft Heinz Co(KHC.O)beat Wall Street expectations for quarterly sales on Wednesday, as the packaged food company benefited from raising product prices to tackle rising inflation.\nNet sales in the third quarter fell to $6.32 billion for the Jell-O maker from $6.44 billion a year earlier. Analysts on average had expected sales of $6.05 billion, according to Refinitiv IBES.\nKraft Heinz Co shares rose nearly 1% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855339262,"gmtCreate":1635334046001,"gmtModify":1635334046274,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855339262","repostId":"1102358032","repostType":4,"isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855339135,"gmtCreate":1635334029849,"gmtModify":1635334030134,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855339135","repostId":"1102358032","repostType":4,"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859405617,"gmtCreate":1634718466839,"gmtModify":1634718481366,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok//<a href=\"https://laohu8.com/U/3579215123116789\">@Steu</a>:ok","listText":"ok//<a href=\"https://laohu8.com/U/3579215123116789\">@Steu</a>:ok","text":"ok//@Steu:ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859405617","repostId":"1167388174","repostType":4,"repost":{"id":"1167388174","kind":"news","pubTimestamp":1633742914,"share":"https://www.laohu8.com/m/news/1167388174?lang=&edition=full","pubTime":"2021-10-09 09:28","market":"us","language":"en","title":"US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167388174","media":"renaissancecap...","summary":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the w","content":"<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.</p>\n<p>Software development platform&nbsp;<b>GitLab</b>(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.</p>\n<p>B2B payments platform&nbsp;<b>AvidXchange</b>(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.</p>\n<p><b>IHS Holding</b>(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.</p>\n<p>Orthopedic medical device company&nbsp;<b>Paragon 28</b>(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.</p>\n<p>Medical diagnostics company&nbsp;<b>Lucid Diagnostics</b>(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.</p>\n<p>ADHD drug developer&nbsp;<b>Cingulate</b>(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.</p>\n<p>Managed health plan provider&nbsp;<b>Marpai</b>(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.</p>\n<p>Dermatological drug spinoff&nbsp;<b>Biofrontera</b>(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.</p>","source":"lsy1625129603274","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 09:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GTLB":"GitLab, Inc.","LUCD":"LUCID DIAGNOSTICS INC.","IHS":"IHS Holding Ltd","AVDX":"AvidXchange Holdings, Inc"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167388174","content_text":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.\nB2B payments platform AvidXchange(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.\nIHS Holding(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.\nOrthopedic medical device company Paragon 28(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.\nMedical diagnostics company Lucid Diagnostics(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.\nADHD drug developer Cingulate(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.\nManaged health plan provider Marpai(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.\nDermatological drug spinoff Biofrontera(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859406269,"gmtCreate":1634718325373,"gmtModify":1634718409531,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"time to short liao","listText":"time to short liao","text":"time to short liao","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859406269","repostId":"1110877432","repostType":4,"repost":{"id":"1110877432","kind":"news","pubTimestamp":1634716002,"share":"https://www.laohu8.com/m/news/1110877432?lang=&edition=full","pubTime":"2021-10-20 15:46","market":"us","language":"en","title":"Tesla Will Probably Beat Earnings Estimates. Why the Stock Might Not Move.","url":"https://stock-news.laohu8.com/highlight/detail?id=1110877432","media":"Barrons","summary":"Tesla will easily beat earnings expectations Wednesday. But that beat might not be enough to drive t","content":"<p>Tesla&nbsp;will easily beat earnings expectations Wednesday. But that beat might not be enough to drive the stock higher.</p>\n<p>For the third quarter, Wall Street expects $1.54 in per-share earnings from $13.7 billion in sales. In the second quarter, Tesla earned $1.45 a sharefrom $12 billion in sales. Wall Street expects the company to make about a dime more on an incremental $1.7 billion in sales.</p>\n<p>Investors, however, need to be ready for the sandbag—when a company guides low and then crushes expectations. That’s usually a good thing. Tesla, however, doesn’t provide guidance, so investors have to rely on Wall Street estimates to judge whether the company “beat” or “missed.” This time around, the estimates from analysts look far too low, creating the possibility of wild post-earnings trading in unexpected directions.</p>\n<p>Things should be better than analysts project. Tesla delivered&nbsp;a record 241,300 vehicles&nbsp;in the third quarter,up from 201,250 in the second quarter. That’s a 20% increase. Tesla’s average price per car in the second quarter amounted to roughly $49,000, and while that number can change, 40,000 more vehicles could easily mean about $2 billion more in sales.</p>\n<p>Wall Street also expects Tesla’s profitability to drop. Gross profit margins are projected to be just below 24%, compared with just above 24% in the second quarter. That might be conservative, just like sales projections. The entire auto industry is dealing with higher costs because of global supply-chain issues. But there’s another reason profitability could be better than current estimates.</p>\n<p>Tesla delivereda record number of cars in China&nbsp;during the third quarter—almost 74,000, up about 20% compared with the second quarter. The cars Tesla produces and sells in China have higher margins than those made there and exported to Europe. With Tesla delivering about 12,000 more vehicles in China during the third quarter compared with the second quarter, profit margins could hold up.</p>\n<p>None of this is a secret, and analysts have been updating their third-quarter earnings estimates—on average, they’re now about a dime per share higher since the end of September. RBC analyst&nbsp;Joe Spaktook his quarterly earnings estimates up to $1.95 a share from $1.68 after delivery results came out. Baird’s&nbsp;Ben Kalloand Wedbush’s&nbsp;Dan Ivesare more optimistic about Tesla’s stock—both have Buy ratings, while Spak rates it a Hold—but neither updated their third-quarter earnings estimates of $1.21 and $1.22 a share, respectively.</p>\n<p>Together, that means the bar for Tesla is much higher than it looks. That’s particularly true because its stock has gained about 30% over the past three months, closing the week at $843.03—even as the&nbsp;S&amp;P 500&nbsp;added 2.6%. That means Tesla will likely need a huge beat to give the stock a jolt, something close to $2 a share.</p>\n<p>Whether it can pull that off remains to be seen.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Will Probably Beat Earnings Estimates. Why the Stock Might Not Move.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Will Probably Beat Earnings Estimates. Why the Stock Might Not Move.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 15:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/tesla-stock-earnings-preview-51634345385?mod=mw_latestnews><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla will easily beat earnings expectations Wednesday. But that beat might not be enough to drive the stock higher.\nFor the third quarter, Wall Street expects $1.54 in per-share earnings from $13.7 ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/tesla-stock-earnings-preview-51634345385?mod=mw_latestnews\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/articles/tesla-stock-earnings-preview-51634345385?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110877432","content_text":"Tesla will easily beat earnings expectations Wednesday. But that beat might not be enough to drive the stock higher.\nFor the third quarter, Wall Street expects $1.54 in per-share earnings from $13.7 billion in sales. In the second quarter, Tesla earned $1.45 a sharefrom $12 billion in sales. Wall Street expects the company to make about a dime more on an incremental $1.7 billion in sales.\nInvestors, however, need to be ready for the sandbag—when a company guides low and then crushes expectations. That’s usually a good thing. Tesla, however, doesn’t provide guidance, so investors have to rely on Wall Street estimates to judge whether the company “beat” or “missed.” This time around, the estimates from analysts look far too low, creating the possibility of wild post-earnings trading in unexpected directions.\nThings should be better than analysts project. Tesla delivered a record 241,300 vehicles in the third quarter,up from 201,250 in the second quarter. That’s a 20% increase. Tesla’s average price per car in the second quarter amounted to roughly $49,000, and while that number can change, 40,000 more vehicles could easily mean about $2 billion more in sales.\nWall Street also expects Tesla’s profitability to drop. Gross profit margins are projected to be just below 24%, compared with just above 24% in the second quarter. That might be conservative, just like sales projections. The entire auto industry is dealing with higher costs because of global supply-chain issues. But there’s another reason profitability could be better than current estimates.\nTesla delivereda record number of cars in China during the third quarter—almost 74,000, up about 20% compared with the second quarter. The cars Tesla produces and sells in China have higher margins than those made there and exported to Europe. With Tesla delivering about 12,000 more vehicles in China during the third quarter compared with the second quarter, profit margins could hold up.\nNone of this is a secret, and analysts have been updating their third-quarter earnings estimates—on average, they’re now about a dime per share higher since the end of September. RBC analyst Joe Spaktook his quarterly earnings estimates up to $1.95 a share from $1.68 after delivery results came out. Baird’s Ben Kalloand Wedbush’s Dan Ivesare more optimistic about Tesla’s stock—both have Buy ratings, while Spak rates it a Hold—but neither updated their third-quarter earnings estimates of $1.21 and $1.22 a share, respectively.\nTogether, that means the bar for Tesla is much higher than it looks. That’s particularly true because its stock has gained about 30% over the past three months, closing the week at $843.03—even as the S&P 500 added 2.6%. That means Tesla will likely need a huge beat to give the stock a jolt, something close to $2 a share.\nWhether it can pull that off remains to be seen.","news_type":1},"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824612787,"gmtCreate":1634307785968,"gmtModify":1634307922717,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>just call, this is oversell","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>just call, this is oversell","text":"$Tiger Brokers(TIGR)$just call, this is oversell","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824612787","isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821708369,"gmtCreate":1633783732632,"gmtModify":1633783732881,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":12,"repostSize":0,"link":"https://laohu8.com/post/821708369","repostId":"1167388174","repostType":4,"repost":{"id":"1167388174","kind":"news","pubTimestamp":1633742914,"share":"https://www.laohu8.com/m/news/1167388174?lang=&edition=full","pubTime":"2021-10-09 09:28","market":"us","language":"en","title":"US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167388174","media":"renaissancecap...","summary":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the w","content":"<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.</p>\n<p>Software development platform&nbsp;<b>GitLab</b>(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.</p>\n<p>B2B payments platform&nbsp;<b>AvidXchange</b>(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.</p>\n<p><b>IHS Holding</b>(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.</p>\n<p>Orthopedic medical device company&nbsp;<b>Paragon 28</b>(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.</p>\n<p>Medical diagnostics company&nbsp;<b>Lucid Diagnostics</b>(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.</p>\n<p>ADHD drug developer&nbsp;<b>Cingulate</b>(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.</p>\n<p>Managed health plan provider&nbsp;<b>Marpai</b>(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.</p>\n<p>Dermatological drug spinoff&nbsp;<b>Biofrontera</b>(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.</p>","source":"lsy1625129603274","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 09:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GTLB":"GitLab, Inc.","LUCD":"LUCID DIAGNOSTICS INC.","IHS":"IHS Holding Ltd","AVDX":"AvidXchange Holdings, Inc"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167388174","content_text":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.\nB2B payments platform AvidXchange(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.\nIHS Holding(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.\nOrthopedic medical device company Paragon 28(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.\nMedical diagnostics company Lucid Diagnostics(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.\nADHD drug developer Cingulate(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.\nManaged health plan provider Marpai(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.\nDermatological drug spinoff Biofrontera(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823749960,"gmtCreate":1633666152501,"gmtModify":1633666153504,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/823749960","repostId":"2173194725","repostType":4,"isVote":1,"tweetType":1,"viewCount":829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820497639,"gmtCreate":1633412335197,"gmtModify":1633412336226,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820497639","repostId":"2170270586","repostType":4,"repost":{"id":"2170270586","kind":"news","pubTimestamp":1633395307,"share":"https://www.laohu8.com/m/news/2170270586?lang=&edition=full","pubTime":"2021-10-05 08:55","market":"fut","language":"en","title":"5 Stocks To Watch As Oil Nears $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2170270586","media":"Oilprice.com","summary":"The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding","content":"<p>The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding to multi-year highs. Brent crude is creeping closer to the magical number of $80/bbl, its best level since October 2018, while WTI was quoted at $75.51/bbl on Monday intraday trading, scoring the highest settlement since July.</p>\n<p>Oil and gas stocks have followed suit, with the energy sector's broad benchmark, the <b>Energy Select Sector SPDR ETF</b> (NYSEARCA:XLE), up 34.3% year-to-date.</p>\n<p>But Big Oil stocks have nothing on their smaller brethren.</p>\n<p>The small-cap favorite benchmark, the <b>PowerShares S&amp;P SmallCap Energy </b>(PSCE), has nearly doubled the gains by large oil stocks with a 63.1% YTD return, a sharp turnaround from the situation last year.</p>\n<p>This comes to nobody's surprise, really, since small-cap oil and gas stocks tend to underperform during bust cycles due to their higher leverage, but also outperform during boom cycles.</p>\n<p>Here are the best-performing small-cap oil stocks so far this year, but caution is necessary because in today's market, \"performing well\" doesn't necessarily mean what it used to before the retail investor craze.</p>\n<p><b>#1. Invesco S&amp;P SmallCap Energy ETF</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AUM: $132M</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 63.1%</b></p>\n<p>The <b>Invesco S&amp;P SmallCap Energy ETF</b> (NASDAQ:PSCE) is an exchange-traded fund launched and managed by Invesco Capital Management LLC. The fund invests in small-cap growth and value stocks of energy companies and seeks to track the performance of the <b>S&amp;P SmallCap 600 Capped Energy Inde</b>x, by using full replication techniques.</p>\n<p><b>Related: Could Oil Pipelines Solve America’s Water Crisis?</b></p>\n<p>PSCE provides investors with exposure to small-cap U.S. energy stocks engaged in the production, distribution, or servicing of energy-related products. Outside of PSCE's returns, the fund also has $132M assets under management, an expense ratio of 0.29%, and 33 holdings.</p>\n<p>Top 5 Holdings are:</p>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/PDCE\">PDC Energy</a> Inc</b>--9.81%</li>\n <li><b><a href=\"https://laohu8.com/S/RRC\">Range Resources</a> Corp</b>--8.98%</li>\n <li><b><a href=\"https://laohu8.com/S/MTDR\">Matador Resources</a> Co</b>--7.47%</li>\n <li><b><a href=\"https://laohu8.com/S/SWNC\">Southwestern Energy Co</a></b>--6.99%</li>\n <li><b>Helmerich &amp; Payne Inc</b>.--6.87%</li>\n</ul>\n<p><b>#2. Ring Energy</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $263.3M</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 301.6%</b></p>\n<p><b>Ring Energy, Inc.</b> (NYSE:REI), is an exploration and production company that engages in the acquisition, exploration, development, and production of oil and natural gas in Texas and New Mexico.</p>\n<p>As of December 31, 2020, the company proved reserves consisted of approximately 76.5 million barrels of oil equivalent(BOE) as well as interests in 45,000 net developed acres and another 31,700 net undeveloped acres. Ring Energy, Inc. primarily sells its oil and natural gas production to end users, marketers, and other purchasers.</p>\n<p>In April 2020, REI announced that it had entered into a purchase and sale agreement on its Delaware Basin Acreage consisting of approximately 20,000 net acres with a sale price of $31.5 million.</p>\n<p>The company has received a $500,000 non-refundable deposit, and had received $5.5 million in non-refundable deposits, or 17% of the original purchase price, by the time the deal fell through in October 2020.</p>\n<p>The considerable non-refundable deposits that Ring Energy received painted it in a good light by proving the value of its assets to shareholders. The company is also likely to receive considerably more for the same asset in the future, given that oil prices have climbed more than 30% since then.</p>\n<p><b>#3.Range Resources Corporation</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $4.9B</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Share Returns: 204.2%%</b></p>\n<p>Operating in the gas-rich Marcellus Formation in Texas,<b> Range Resources </b>(NYSE:RRC) is the 8th largest U.S. shale gas producer. As of December 31, 2020, the company owned and operated 1,310 net producing wells and approximately 781,000 net acres under lease located in the Appalachian region of the northeastern United States. The company's acreage is superior to that of most of its peers, which allows it to enjoy a lower decline rate and more efficient operations.</p>\n<p>Recently, <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> picked Range Resources together with its shale gas peer <b>Antero Resource</b>s (NYSE:AR) as their favorite gas stocks because their outsized exposure to liquids still makes sense with the growing prospects of a propane supply squeeze. Propane's trading at 75% of WTI, significantly above the more typical low 50s percentage for this time of year, with the Wall Street bank remaining bullish on LPG prices.</p>\n<p><b>#4. Matador Resources Company</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $3.9B</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 177.8%</b></p>\n<p>Dallas-based <b>Matador Resources Company</b> (NYSE:MTDR) is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. It operates in two segments, Exploration and Production(E&amp;P) and Midstream. The company primarily holds interests in the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. It also operates the Eagle Ford shale play in South Texas and the Haynesville shale and Cotton Valley plays in Northwest Louisiana.</p>\n<p><b>Related: China Oil Consumption Seen Peaking In 5 Years</b></p>\n<p>As of December 31, 2020, Matador had an estimated total proved oil and natural gas reserves of 270.3 million barrels of oil equivalent, including 159.9 million stock tank barrels of oil and 662.3 billion cubic feet of natural gas.</p>\n<p>A couple of weeks ago, J.P. Morgan and upgraded <b>Matador Resources</b> (NYSE:MTDR) Overweight from Neutral in part due to continued operational outperformance.</p>\n<p><b>#5. PDC Energy</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $4.6B</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 128.9%</b></p>\n<p>J.P. Morgan recently picked seven narratives playing out in oil and gas E&amp;Ps. One of J.P. Morgan's fall \"playbook\" for oil and gas exploration and production companies are those with the highest potential return of \"significant\" levels of free cash flow to equity holders--rather than merely using it for reducing debt, as most oil and gas companies have done this year. Indeed, JPM says that since the end of 2020, companies in the firm's coverage group have cut net debt by $9.65 billion through balance sheets of June 30.</p>\n<p><b>PDC Energy</b> (NASDAQ:PDCE) is <a href=\"https://laohu8.com/S/AONE.U\">one</a> such company that has announced cash return strategies beyond normal dividends.</p>\n<p>PDC Energy is an independent exploration and production company that produces crude oil, natural gas, and natural gas liquids in the United States. The company's operations are primarily located in the Wattenberg Field in Colorado and the Delaware Basin in Texas. As of December 31, 2020, it owned interests in approximately 3,727 productive gross wells.</p>\n<p>JPM also favors PDCE as a top pick because:</p>\n<p>\"<i>We think that the current price environment remains a 'sweet spot,' with demand gradually recovering from COVID-19 and the OPEC/shale market share war remaining fairly subdued largely driven by public company shale discipline</i>.\"</p>\n<p>By Alex Kimani for Oilprice.com</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch As Oil Nears $80</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch As Oil Nears $80\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 08:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/5-stocks-watch-oil-nears-230000255.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding to multi-year highs. Brent crude is creeping closer to the magical number of $80/bbl, its best ...</p>\n\n<a href=\"https://finance.yahoo.com/news/5-stocks-watch-oil-nears-230000255.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XLE":"SPDR能源指数ETF","PDCE":"PDC Energy","REI":"Ring Energy Inc.","RRC":"山脉资源","MTDR":"Matador Resources"},"source_url":"https://finance.yahoo.com/news/5-stocks-watch-oil-nears-230000255.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2170270586","content_text":"The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding to multi-year highs. Brent crude is creeping closer to the magical number of $80/bbl, its best level since October 2018, while WTI was quoted at $75.51/bbl on Monday intraday trading, scoring the highest settlement since July.\nOil and gas stocks have followed suit, with the energy sector's broad benchmark, the Energy Select Sector SPDR ETF (NYSEARCA:XLE), up 34.3% year-to-date.\nBut Big Oil stocks have nothing on their smaller brethren.\nThe small-cap favorite benchmark, the PowerShares S&P SmallCap Energy (PSCE), has nearly doubled the gains by large oil stocks with a 63.1% YTD return, a sharp turnaround from the situation last year.\nThis comes to nobody's surprise, really, since small-cap oil and gas stocks tend to underperform during bust cycles due to their higher leverage, but also outperform during boom cycles.\nHere are the best-performing small-cap oil stocks so far this year, but caution is necessary because in today's market, \"performing well\" doesn't necessarily mean what it used to before the retail investor craze.\n#1. Invesco S&P SmallCap Energy ETF\n       AUM: $132M\n       YTD Returns: 63.1%\nThe Invesco S&P SmallCap Energy ETF (NASDAQ:PSCE) is an exchange-traded fund launched and managed by Invesco Capital Management LLC. The fund invests in small-cap growth and value stocks of energy companies and seeks to track the performance of the S&P SmallCap 600 Capped Energy Index, by using full replication techniques.\nRelated: Could Oil Pipelines Solve America’s Water Crisis?\nPSCE provides investors with exposure to small-cap U.S. energy stocks engaged in the production, distribution, or servicing of energy-related products. Outside of PSCE's returns, the fund also has $132M assets under management, an expense ratio of 0.29%, and 33 holdings.\nTop 5 Holdings are:\n\nPDC Energy Inc--9.81%\nRange Resources Corp--8.98%\nMatador Resources Co--7.47%\nSouthwestern Energy Co--6.99%\nHelmerich & Payne Inc.--6.87%\n\n#2. Ring Energy\n      Market Cap: $263.3M\n      YTD Returns: 301.6%\nRing Energy, Inc. (NYSE:REI), is an exploration and production company that engages in the acquisition, exploration, development, and production of oil and natural gas in Texas and New Mexico.\nAs of December 31, 2020, the company proved reserves consisted of approximately 76.5 million barrels of oil equivalent(BOE) as well as interests in 45,000 net developed acres and another 31,700 net undeveloped acres. Ring Energy, Inc. primarily sells its oil and natural gas production to end users, marketers, and other purchasers.\nIn April 2020, REI announced that it had entered into a purchase and sale agreement on its Delaware Basin Acreage consisting of approximately 20,000 net acres with a sale price of $31.5 million.\nThe company has received a $500,000 non-refundable deposit, and had received $5.5 million in non-refundable deposits, or 17% of the original purchase price, by the time the deal fell through in October 2020.\nThe considerable non-refundable deposits that Ring Energy received painted it in a good light by proving the value of its assets to shareholders. The company is also likely to receive considerably more for the same asset in the future, given that oil prices have climbed more than 30% since then.\n#3.Range Resources Corporation\n      Market Cap: $4.9B\n      YTD Share Returns: 204.2%%\nOperating in the gas-rich Marcellus Formation in Texas, Range Resources (NYSE:RRC) is the 8th largest U.S. shale gas producer. As of December 31, 2020, the company owned and operated 1,310 net producing wells and approximately 781,000 net acres under lease located in the Appalachian region of the northeastern United States. The company's acreage is superior to that of most of its peers, which allows it to enjoy a lower decline rate and more efficient operations.\nRecently, Morgan Stanley picked Range Resources together with its shale gas peer Antero Resources (NYSE:AR) as their favorite gas stocks because their outsized exposure to liquids still makes sense with the growing prospects of a propane supply squeeze. Propane's trading at 75% of WTI, significantly above the more typical low 50s percentage for this time of year, with the Wall Street bank remaining bullish on LPG prices.\n#4. Matador Resources Company\n      Market Cap: $3.9B\n      YTD Returns: 177.8%\nDallas-based Matador Resources Company (NYSE:MTDR) is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. It operates in two segments, Exploration and Production(E&P) and Midstream. The company primarily holds interests in the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. It also operates the Eagle Ford shale play in South Texas and the Haynesville shale and Cotton Valley plays in Northwest Louisiana.\nRelated: China Oil Consumption Seen Peaking In 5 Years\nAs of December 31, 2020, Matador had an estimated total proved oil and natural gas reserves of 270.3 million barrels of oil equivalent, including 159.9 million stock tank barrels of oil and 662.3 billion cubic feet of natural gas.\nA couple of weeks ago, J.P. Morgan and upgraded Matador Resources (NYSE:MTDR) Overweight from Neutral in part due to continued operational outperformance.\n#5. PDC Energy\n      Market Cap: $4.6B\n      YTD Returns: 128.9%\nJ.P. Morgan recently picked seven narratives playing out in oil and gas E&Ps. One of J.P. Morgan's fall \"playbook\" for oil and gas exploration and production companies are those with the highest potential return of \"significant\" levels of free cash flow to equity holders--rather than merely using it for reducing debt, as most oil and gas companies have done this year. Indeed, JPM says that since the end of 2020, companies in the firm's coverage group have cut net debt by $9.65 billion through balance sheets of June 30.\nPDC Energy (NASDAQ:PDCE) is one such company that has announced cash return strategies beyond normal dividends.\nPDC Energy is an independent exploration and production company that produces crude oil, natural gas, and natural gas liquids in the United States. The company's operations are primarily located in the Wattenberg Field in Colorado and the Delaware Basin in Texas. As of December 31, 2020, it owned interests in approximately 3,727 productive gross wells.\nJPM also favors PDCE as a top pick because:\n\"We think that the current price environment remains a 'sweet spot,' with demand gradually recovering from COVID-19 and the OPEC/shale market share war remaining fairly subdued largely driven by public company shale discipline.\"\nBy Alex Kimani for Oilprice.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820497964,"gmtCreate":1633412290278,"gmtModify":1633412291225,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820497964","repostId":"2170270586","repostType":4,"repost":{"id":"2170270586","kind":"news","pubTimestamp":1633395307,"share":"https://www.laohu8.com/m/news/2170270586?lang=&edition=full","pubTime":"2021-10-05 08:55","market":"fut","language":"en","title":"5 Stocks To Watch As Oil Nears $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2170270586","media":"Oilprice.com","summary":"The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding","content":"<p>The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding to multi-year highs. Brent crude is creeping closer to the magical number of $80/bbl, its best level since October 2018, while WTI was quoted at $75.51/bbl on Monday intraday trading, scoring the highest settlement since July.</p>\n<p>Oil and gas stocks have followed suit, with the energy sector's broad benchmark, the <b>Energy Select Sector SPDR ETF</b> (NYSEARCA:XLE), up 34.3% year-to-date.</p>\n<p>But Big Oil stocks have nothing on their smaller brethren.</p>\n<p>The small-cap favorite benchmark, the <b>PowerShares S&amp;P SmallCap Energy </b>(PSCE), has nearly doubled the gains by large oil stocks with a 63.1% YTD return, a sharp turnaround from the situation last year.</p>\n<p>This comes to nobody's surprise, really, since small-cap oil and gas stocks tend to underperform during bust cycles due to their higher leverage, but also outperform during boom cycles.</p>\n<p>Here are the best-performing small-cap oil stocks so far this year, but caution is necessary because in today's market, \"performing well\" doesn't necessarily mean what it used to before the retail investor craze.</p>\n<p><b>#1. Invesco S&amp;P SmallCap Energy ETF</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AUM: $132M</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 63.1%</b></p>\n<p>The <b>Invesco S&amp;P SmallCap Energy ETF</b> (NASDAQ:PSCE) is an exchange-traded fund launched and managed by Invesco Capital Management LLC. The fund invests in small-cap growth and value stocks of energy companies and seeks to track the performance of the <b>S&amp;P SmallCap 600 Capped Energy Inde</b>x, by using full replication techniques.</p>\n<p><b>Related: Could Oil Pipelines Solve America’s Water Crisis?</b></p>\n<p>PSCE provides investors with exposure to small-cap U.S. energy stocks engaged in the production, distribution, or servicing of energy-related products. Outside of PSCE's returns, the fund also has $132M assets under management, an expense ratio of 0.29%, and 33 holdings.</p>\n<p>Top 5 Holdings are:</p>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/PDCE\">PDC Energy</a> Inc</b>--9.81%</li>\n <li><b><a href=\"https://laohu8.com/S/RRC\">Range Resources</a> Corp</b>--8.98%</li>\n <li><b><a href=\"https://laohu8.com/S/MTDR\">Matador Resources</a> Co</b>--7.47%</li>\n <li><b><a href=\"https://laohu8.com/S/SWNC\">Southwestern Energy Co</a></b>--6.99%</li>\n <li><b>Helmerich &amp; Payne Inc</b>.--6.87%</li>\n</ul>\n<p><b>#2. Ring Energy</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $263.3M</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 301.6%</b></p>\n<p><b>Ring Energy, Inc.</b> (NYSE:REI), is an exploration and production company that engages in the acquisition, exploration, development, and production of oil and natural gas in Texas and New Mexico.</p>\n<p>As of December 31, 2020, the company proved reserves consisted of approximately 76.5 million barrels of oil equivalent(BOE) as well as interests in 45,000 net developed acres and another 31,700 net undeveloped acres. Ring Energy, Inc. primarily sells its oil and natural gas production to end users, marketers, and other purchasers.</p>\n<p>In April 2020, REI announced that it had entered into a purchase and sale agreement on its Delaware Basin Acreage consisting of approximately 20,000 net acres with a sale price of $31.5 million.</p>\n<p>The company has received a $500,000 non-refundable deposit, and had received $5.5 million in non-refundable deposits, or 17% of the original purchase price, by the time the deal fell through in October 2020.</p>\n<p>The considerable non-refundable deposits that Ring Energy received painted it in a good light by proving the value of its assets to shareholders. The company is also likely to receive considerably more for the same asset in the future, given that oil prices have climbed more than 30% since then.</p>\n<p><b>#3.Range Resources Corporation</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $4.9B</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Share Returns: 204.2%%</b></p>\n<p>Operating in the gas-rich Marcellus Formation in Texas,<b> Range Resources </b>(NYSE:RRC) is the 8th largest U.S. shale gas producer. As of December 31, 2020, the company owned and operated 1,310 net producing wells and approximately 781,000 net acres under lease located in the Appalachian region of the northeastern United States. The company's acreage is superior to that of most of its peers, which allows it to enjoy a lower decline rate and more efficient operations.</p>\n<p>Recently, <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> picked Range Resources together with its shale gas peer <b>Antero Resource</b>s (NYSE:AR) as their favorite gas stocks because their outsized exposure to liquids still makes sense with the growing prospects of a propane supply squeeze. Propane's trading at 75% of WTI, significantly above the more typical low 50s percentage for this time of year, with the Wall Street bank remaining bullish on LPG prices.</p>\n<p><b>#4. Matador Resources Company</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $3.9B</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 177.8%</b></p>\n<p>Dallas-based <b>Matador Resources Company</b> (NYSE:MTDR) is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. It operates in two segments, Exploration and Production(E&amp;P) and Midstream. The company primarily holds interests in the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. It also operates the Eagle Ford shale play in South Texas and the Haynesville shale and Cotton Valley plays in Northwest Louisiana.</p>\n<p><b>Related: China Oil Consumption Seen Peaking In 5 Years</b></p>\n<p>As of December 31, 2020, Matador had an estimated total proved oil and natural gas reserves of 270.3 million barrels of oil equivalent, including 159.9 million stock tank barrels of oil and 662.3 billion cubic feet of natural gas.</p>\n<p>A couple of weeks ago, J.P. Morgan and upgraded <b>Matador Resources</b> (NYSE:MTDR) Overweight from Neutral in part due to continued operational outperformance.</p>\n<p><b>#5. PDC Energy</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market Cap: $4.6B</b></p>\n<p><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YTD Returns: 128.9%</b></p>\n<p>J.P. Morgan recently picked seven narratives playing out in oil and gas E&amp;Ps. One of J.P. Morgan's fall \"playbook\" for oil and gas exploration and production companies are those with the highest potential return of \"significant\" levels of free cash flow to equity holders--rather than merely using it for reducing debt, as most oil and gas companies have done this year. Indeed, JPM says that since the end of 2020, companies in the firm's coverage group have cut net debt by $9.65 billion through balance sheets of June 30.</p>\n<p><b>PDC Energy</b> (NASDAQ:PDCE) is <a href=\"https://laohu8.com/S/AONE.U\">one</a> such company that has announced cash return strategies beyond normal dividends.</p>\n<p>PDC Energy is an independent exploration and production company that produces crude oil, natural gas, and natural gas liquids in the United States. The company's operations are primarily located in the Wattenberg Field in Colorado and the Delaware Basin in Texas. As of December 31, 2020, it owned interests in approximately 3,727 productive gross wells.</p>\n<p>JPM also favors PDCE as a top pick because:</p>\n<p>\"<i>We think that the current price environment remains a 'sweet spot,' with demand gradually recovering from COVID-19 and the OPEC/shale market share war remaining fairly subdued largely driven by public company shale discipline</i>.\"</p>\n<p>By Alex Kimani for Oilprice.com</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch As Oil Nears $80</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch As Oil Nears $80\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 08:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/5-stocks-watch-oil-nears-230000255.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding to multi-year highs. Brent crude is creeping closer to the magical number of $80/bbl, its best ...</p>\n\n<a href=\"https://finance.yahoo.com/news/5-stocks-watch-oil-nears-230000255.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XLE":"SPDR能源指数ETF","PDCE":"PDC Energy","REI":"Ring Energy Inc.","RRC":"山脉资源","MTDR":"Matador Resources"},"source_url":"https://finance.yahoo.com/news/5-stocks-watch-oil-nears-230000255.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2170270586","content_text":"The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding to multi-year highs. Brent crude is creeping closer to the magical number of $80/bbl, its best level since October 2018, while WTI was quoted at $75.51/bbl on Monday intraday trading, scoring the highest settlement since July.\nOil and gas stocks have followed suit, with the energy sector's broad benchmark, the Energy Select Sector SPDR ETF (NYSEARCA:XLE), up 34.3% year-to-date.\nBut Big Oil stocks have nothing on their smaller brethren.\nThe small-cap favorite benchmark, the PowerShares S&P SmallCap Energy (PSCE), has nearly doubled the gains by large oil stocks with a 63.1% YTD return, a sharp turnaround from the situation last year.\nThis comes to nobody's surprise, really, since small-cap oil and gas stocks tend to underperform during bust cycles due to their higher leverage, but also outperform during boom cycles.\nHere are the best-performing small-cap oil stocks so far this year, but caution is necessary because in today's market, \"performing well\" doesn't necessarily mean what it used to before the retail investor craze.\n#1. Invesco S&P SmallCap Energy ETF\n       AUM: $132M\n       YTD Returns: 63.1%\nThe Invesco S&P SmallCap Energy ETF (NASDAQ:PSCE) is an exchange-traded fund launched and managed by Invesco Capital Management LLC. The fund invests in small-cap growth and value stocks of energy companies and seeks to track the performance of the S&P SmallCap 600 Capped Energy Index, by using full replication techniques.\nRelated: Could Oil Pipelines Solve America’s Water Crisis?\nPSCE provides investors with exposure to small-cap U.S. energy stocks engaged in the production, distribution, or servicing of energy-related products. Outside of PSCE's returns, the fund also has $132M assets under management, an expense ratio of 0.29%, and 33 holdings.\nTop 5 Holdings are:\n\nPDC Energy Inc--9.81%\nRange Resources Corp--8.98%\nMatador Resources Co--7.47%\nSouthwestern Energy Co--6.99%\nHelmerich & Payne Inc.--6.87%\n\n#2. Ring Energy\n      Market Cap: $263.3M\n      YTD Returns: 301.6%\nRing Energy, Inc. (NYSE:REI), is an exploration and production company that engages in the acquisition, exploration, development, and production of oil and natural gas in Texas and New Mexico.\nAs of December 31, 2020, the company proved reserves consisted of approximately 76.5 million barrels of oil equivalent(BOE) as well as interests in 45,000 net developed acres and another 31,700 net undeveloped acres. Ring Energy, Inc. primarily sells its oil and natural gas production to end users, marketers, and other purchasers.\nIn April 2020, REI announced that it had entered into a purchase and sale agreement on its Delaware Basin Acreage consisting of approximately 20,000 net acres with a sale price of $31.5 million.\nThe company has received a $500,000 non-refundable deposit, and had received $5.5 million in non-refundable deposits, or 17% of the original purchase price, by the time the deal fell through in October 2020.\nThe considerable non-refundable deposits that Ring Energy received painted it in a good light by proving the value of its assets to shareholders. The company is also likely to receive considerably more for the same asset in the future, given that oil prices have climbed more than 30% since then.\n#3.Range Resources Corporation\n      Market Cap: $4.9B\n      YTD Share Returns: 204.2%%\nOperating in the gas-rich Marcellus Formation in Texas, Range Resources (NYSE:RRC) is the 8th largest U.S. shale gas producer. As of December 31, 2020, the company owned and operated 1,310 net producing wells and approximately 781,000 net acres under lease located in the Appalachian region of the northeastern United States. The company's acreage is superior to that of most of its peers, which allows it to enjoy a lower decline rate and more efficient operations.\nRecently, Morgan Stanley picked Range Resources together with its shale gas peer Antero Resources (NYSE:AR) as their favorite gas stocks because their outsized exposure to liquids still makes sense with the growing prospects of a propane supply squeeze. Propane's trading at 75% of WTI, significantly above the more typical low 50s percentage for this time of year, with the Wall Street bank remaining bullish on LPG prices.\n#4. Matador Resources Company\n      Market Cap: $3.9B\n      YTD Returns: 177.8%\nDallas-based Matador Resources Company (NYSE:MTDR) is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. It operates in two segments, Exploration and Production(E&P) and Midstream. The company primarily holds interests in the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. It also operates the Eagle Ford shale play in South Texas and the Haynesville shale and Cotton Valley plays in Northwest Louisiana.\nRelated: China Oil Consumption Seen Peaking In 5 Years\nAs of December 31, 2020, Matador had an estimated total proved oil and natural gas reserves of 270.3 million barrels of oil equivalent, including 159.9 million stock tank barrels of oil and 662.3 billion cubic feet of natural gas.\nA couple of weeks ago, J.P. Morgan and upgraded Matador Resources (NYSE:MTDR) Overweight from Neutral in part due to continued operational outperformance.\n#5. PDC Energy\n      Market Cap: $4.6B\n      YTD Returns: 128.9%\nJ.P. Morgan recently picked seven narratives playing out in oil and gas E&Ps. One of J.P. Morgan's fall \"playbook\" for oil and gas exploration and production companies are those with the highest potential return of \"significant\" levels of free cash flow to equity holders--rather than merely using it for reducing debt, as most oil and gas companies have done this year. Indeed, JPM says that since the end of 2020, companies in the firm's coverage group have cut net debt by $9.65 billion through balance sheets of June 30.\nPDC Energy (NASDAQ:PDCE) is one such company that has announced cash return strategies beyond normal dividends.\nPDC Energy is an independent exploration and production company that produces crude oil, natural gas, and natural gas liquids in the United States. The company's operations are primarily located in the Wattenberg Field in Colorado and the Delaware Basin in Texas. As of December 31, 2020, it owned interests in approximately 3,727 productive gross wells.\nJPM also favors PDCE as a top pick because:\n\"We think that the current price environment remains a 'sweet spot,' with demand gradually recovering from COVID-19 and the OPEC/shale market share war remaining fairly subdued largely driven by public company shale discipline.\"\nBy Alex Kimani for Oilprice.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820494432,"gmtCreate":1633412270854,"gmtModify":1633412271744,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820494432","repostId":"2172968917","repostType":4,"repost":{"id":"2172968917","kind":"highlight","pubTimestamp":1633395971,"share":"https://www.laohu8.com/m/news/2172968917?lang=&edition=full","pubTime":"2021-10-05 09:06","market":"us","language":"en","title":"Why Adobe Stock Is a Buy for the Coming $10 Trillion \"Digital Transformation\" Boom","url":"https://stock-news.laohu8.com/highlight/detail?id=2172968917","media":"Motley Fool","summary":"Don't let a ho-hum September keep you away from this long-term winner.","content":"<p><b><a href=\"https://laohu8.com/S/ADBE\">Adobe</a> </b>(NASDAQ:ADBE) has hit the skids since its fiscal 2021 third quarter update in September. Shares are down some 12% on the month, putting the tech stock officially in \"correction\" territory. It's not that the report itself was bad, but fears that the software giant is \"overpriced\" and political angst caused by the U.S. debt limit debate have arisen.</p>\n<p>However, Adobe's cloud-based software is a key ingredient for getting work done these days and is still a fantastic long-term buy, especially with trillions of dollars expected to be spent on digital transformation tools like what Adobe offers.&nbsp;Here are three reasons to stay optimistic.</p>\n<h2>1. Adobe is a top partner for digital makeovers</h2>\n<p>Digital transformation (DX from here on out) is all the rage in the software community right now. Cloud computing was already promising to make business operations vastly more efficient and intuitive than in the past, but the pandemic proved beyond a doubt that the movement is the real deal. A frenzy of digital updates in the corporate world are now underway and could last for many years to come.</p>\n<p><img src=\"https://static.tigerbbs.com/b24d2cfc080b5567e11b770d940b9a41\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>To drive home the point, we can borrow a statistic from tech researcher IDC -- <a href=\"https://laohu8.com/S/AONE.U\">one</a> that Adobe peer and fellow DX champion <b>salesforce.com </b>(NYSE:CRM) shared recently during its investor day. IDC thinks no less than $10 trillion will be spent on DX initiatives from 2019 through 2024, and 57% of total global IT spend will be on DX by 2024 compared to just 42% in 2020.</p>\n<p>While Adobe can only address a fraction of this huge spending spree, its focus on cloud-based creativity, marketing, document management, and customer engagement software positions it as a potential primary partner for any firm looking to get with the times. Having hauled in $15 billion in sales over the last 12 months, Adobe is a massive firm already. But given the relentlessly rising demand for its software,&nbsp;Adobe has no shortage of room to get much larger.</p>\n<h2>2. A highly profitable growth business</h2>\n<p>Adobe is undeniably a fantastic -- and perhaps underrated -- long-term growth story. It's been growing revenue at a double-digit percentage clip for years, and the company thinks momentum will continue. For the final quarter of fiscal 2021, management is forecasting about a 19% year-over-year increase in sales to $4.07 billion.</p>\n<p>But this stock isn't just for investors with a growth mindset. Adobe is wildly profitable, too. It's been generating operating profit margins of well over 20% over the last decade, and operating margin was at 36% over the last 12-month stretch. With its sticky suite of subscription-based creativity and data management software poised to continue growing, those lucrative profit margins aren't going away anytime soon.</p>\n<p>Pairing those consistent profits with double-digit sales expansion and a valuation currently at 48 times trailing-12-month earnings, a case could be made that Adobe is a value stock hiding in growth stock clothing.</p>\n<h2>3. A superb balance sheet that's constantly being replenished</h2>\n<p>As of Sept. 3, 2021, Adobe had $6.16 billion in cash and equivalents on the books, offset by debt of just $4.12 billion. Its cash hoard is constantly being fed, too. Adobe generated $6.61 billion of free cash flow in the last 12 months, some of which it added to the balance sheet. But management also returns an ample amount to shareholders. Adobe doesn't pay a dividend, but it does repurchase stock. It spent $1 billion in share buybacks during Q3 of fiscal 2021 alone.</p>\n<p>That still leaves plenty of capital for Adobe to invest in new software, or make the occasional acquisition. Its latest purchase: The proposed $1.275 billion takeover of video collaboration platform Frame.io, which boasts over one million users and will integrate with Adobe's existing toolkit for content creators.</p>\n<p>Adobe is still growing fast, generating plenty of profits, and in prime position to help lead its customers into a new digital era. The digital transformation movement is just beginning, so this stock deserves to be a top-of-mind pick to build a portfolio around.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Adobe Stock Is a Buy for the Coming $10 Trillion \"Digital Transformation\" Boom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Adobe Stock Is a Buy for the Coming $10 Trillion \"Digital Transformation\" Boom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/01/3-reasons-adobe-stock-is-a-buy-for-the-coming-10-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Adobe (NASDAQ:ADBE) has hit the skids since its fiscal 2021 third quarter update in September. Shares are down some 12% on the month, putting the tech stock officially in \"correction\" territory. It's ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/01/3-reasons-adobe-stock-is-a-buy-for-the-coming-10-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADBE":"Adobe"},"source_url":"https://www.fool.com/investing/2021/10/01/3-reasons-adobe-stock-is-a-buy-for-the-coming-10-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172968917","content_text":"Adobe (NASDAQ:ADBE) has hit the skids since its fiscal 2021 third quarter update in September. Shares are down some 12% on the month, putting the tech stock officially in \"correction\" territory. It's not that the report itself was bad, but fears that the software giant is \"overpriced\" and political angst caused by the U.S. debt limit debate have arisen.\nHowever, Adobe's cloud-based software is a key ingredient for getting work done these days and is still a fantastic long-term buy, especially with trillions of dollars expected to be spent on digital transformation tools like what Adobe offers. Here are three reasons to stay optimistic.\n1. Adobe is a top partner for digital makeovers\nDigital transformation (DX from here on out) is all the rage in the software community right now. Cloud computing was already promising to make business operations vastly more efficient and intuitive than in the past, but the pandemic proved beyond a doubt that the movement is the real deal. A frenzy of digital updates in the corporate world are now underway and could last for many years to come.\n\nImage source: Getty Images.\nTo drive home the point, we can borrow a statistic from tech researcher IDC -- one that Adobe peer and fellow DX champion salesforce.com (NYSE:CRM) shared recently during its investor day. IDC thinks no less than $10 trillion will be spent on DX initiatives from 2019 through 2024, and 57% of total global IT spend will be on DX by 2024 compared to just 42% in 2020.\nWhile Adobe can only address a fraction of this huge spending spree, its focus on cloud-based creativity, marketing, document management, and customer engagement software positions it as a potential primary partner for any firm looking to get with the times. Having hauled in $15 billion in sales over the last 12 months, Adobe is a massive firm already. But given the relentlessly rising demand for its software, Adobe has no shortage of room to get much larger.\n2. A highly profitable growth business\nAdobe is undeniably a fantastic -- and perhaps underrated -- long-term growth story. It's been growing revenue at a double-digit percentage clip for years, and the company thinks momentum will continue. For the final quarter of fiscal 2021, management is forecasting about a 19% year-over-year increase in sales to $4.07 billion.\nBut this stock isn't just for investors with a growth mindset. Adobe is wildly profitable, too. It's been generating operating profit margins of well over 20% over the last decade, and operating margin was at 36% over the last 12-month stretch. With its sticky suite of subscription-based creativity and data management software poised to continue growing, those lucrative profit margins aren't going away anytime soon.\nPairing those consistent profits with double-digit sales expansion and a valuation currently at 48 times trailing-12-month earnings, a case could be made that Adobe is a value stock hiding in growth stock clothing.\n3. A superb balance sheet that's constantly being replenished\nAs of Sept. 3, 2021, Adobe had $6.16 billion in cash and equivalents on the books, offset by debt of just $4.12 billion. Its cash hoard is constantly being fed, too. Adobe generated $6.61 billion of free cash flow in the last 12 months, some of which it added to the balance sheet. But management also returns an ample amount to shareholders. Adobe doesn't pay a dividend, but it does repurchase stock. It spent $1 billion in share buybacks during Q3 of fiscal 2021 alone.\nThat still leaves plenty of capital for Adobe to invest in new software, or make the occasional acquisition. Its latest purchase: The proposed $1.275 billion takeover of video collaboration platform Frame.io, which boasts over one million users and will integrate with Adobe's existing toolkit for content creators.\nAdobe is still growing fast, generating plenty of profits, and in prime position to help lead its customers into a new digital era. The digital transformation movement is just beginning, so this stock deserves to be a top-of-mind pick to build a portfolio around.","news_type":1},"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864752155,"gmtCreate":1633152925190,"gmtModify":1633152926090,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"嗯<a href=\"https://laohu8.com/S/LI\">$Li Auto(LI)$</a>","listText":"嗯<a href=\"https://laohu8.com/S/LI\">$Li Auto(LI)$</a>","text":"嗯$Li Auto(LI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864752155","repostId":"2172618769","repostType":4,"repost":{"id":"2172618769","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1633152083,"share":"https://www.laohu8.com/m/news/2172618769?lang=&edition=full","pubTime":"2021-10-02 13:21","market":"us","language":"en","title":"Warren Buffett bucks Wall Street by adding more Kroger stock to his portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2172618769","media":"Dow Jones","summary":"Kroger can be seen as both a value pick and a long-term play on the transformation of food shopping. When investors think about the supermarket industry, dynamic growth probably doesn't come to mind. But Berkshire Hathaway CEO Warren Buffett loves Kroger.One reason may be that the stock is cheaply priced relative to earnings estimates. Another is that Kroger Co. KR is ramping up online sales; digital sales increased 16% in the fiscal first quarter ended May 22 from a year earlier and more than d","content":"<p>Kroger can be seen as both a value pick and a long-term play on the transformation of food shopping</p>\n<p>When investors think about the supermarket industry, dynamic growth probably doesn't come to mind. But Berkshire Hathaway CEO Warren Buffett loves Kroger.</p>\n<p>One reason may be that the stock is cheaply priced relative to earnings estimates. Another is that Kroger Co. KR is ramping up online sales; digital sales increased 16% in the fiscal first quarter ended May 22 from a year earlier and more than doubled from two years earlier. More growth could come from the food retailer's plans to build fulfillment centers to handle digital orders.</p>\n<p>Berkshire Hathaway Inc. (BRKA)(BRKA) purchased nearly 11 million shares of Kroger in the second quarter, according to its latest 13F report with the Securities and Exchange Commission. That brings its stake to 61.8 million shares, or about 8.3% of shares outstanding as of May 22, the end of Kroger's fiscal first quarter.</p>\n<p>Read:Warren Buffett's Berkshire Hathaway buys Kroger, cuts stakes in drug makers</p>\n<p>Wall Street doesn't like Kroger</p>\n<p>While Berkshire appears fond of Kroger, which operates as Harris Teeter, Fred Keyer and King Soopers, among others, as well as Kroger, Wall Street is more skeptical.</p>\n<p>Within the Russell 3000 Index, which represents about 98% of the U.S. stock market by market capitalization, there are only 10 companies in the \"food retail\" industry group, according to FactSet. Here they are, sorted by market capitalization, along with forward price-to-earnings ratios.</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Market cap. ($mil)</td>\n   <td>Forward P/E</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>$422,424</td>\n   <td>24.9</td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>$32,467</td>\n   <td>15.0</td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>$13,688</td>\n   <td>13.5</td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc. SFM</td>\n   <td>$2,767</td>\n   <td>12.3</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GO\">Grocery Outlet Holding</a> Corp. GO</td>\n   <td>$2,565</td>\n   <td>27.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WMK\">Weis Markets Inc</a>. WMK</td>\n   <td>$1,502</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>Arko Corp. ARKO</td>\n   <td>$1,033</td>\n   <td>16.5</td>\n  </tr>\n  <tr>\n   <td>Ingles Markets Inc. Class A IMKTA</td>\n   <td>$917</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>Natural Grocers by Vitamin Cottage Inc. NGVC</td>\n   <td>$264</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/VLGEA\">Village Super Market</a> Inc. Class A VLGEA</td>\n   <td>$233</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td></td>\n   <td>For comparison, the S&amp;P 500 index</td>\n   <td>has a weighted forward P/E of 21.4, according to FactSet.</td>\n  </tr>\n </tbody>\n</table>\n<p>There are no P/E ratios for four of these companies because consensus earnings estimates aren't available. Three aren't covered by any analysts polled by FactSet, while Natural Grocers by Vitamin Cottage Inc. <a href=\"https://laohu8.com/S/NGVC\">$(NGVC)$</a> is covered by only <a href=\"https://laohu8.com/S/AONE.U\">one</a> analyst.</p>\n<p>For the six companies covered by at least four analysts, here's a summary of ratings and price targets:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Share \"buy\" ratings</td>\n   <td>Share</td>\n   <td>neutral ratings</td>\n   <td>Share \"sell\" ratings</td>\n   <td>Closing price -- Aug. 16</td>\n   <td>Consensus price target</td>\n   <td>implied 12-month upside potential</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>75%</td>\n   <td>19%</td>\n   <td>6%</td>\n   <td>$152.34</td>\n   <td>$165.10</td>\n   <td>8%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>21%</td>\n   <td>54%</td>\n   <td>25%</td>\n   <td>$45.43</td>\n   <td>$38.49</td>\n   <td>-15%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>55%</td>\n   <td>40%</td>\n   <td>5%</td>\n   <td>$30.04</td>\n   <td>$25.28</td>\n   <td>-16%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc.</td>\n   <td>25%</td>\n   <td>50%</td>\n   <td>25%</td>\n   <td>$24.55</td>\n   <td>$26.50</td>\n   <td>8%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Grocery Outlet Holding Corp.</td>\n   <td>33%</td>\n   <td>60%</td>\n   <td>7%</td>\n   <td>$26.63</td>\n   <td>$34.36</td>\n   <td>29%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Arko Corp.</td>\n   <td>100%</td>\n   <td>0%</td>\n   <td>0%</td>\n   <td>$8.15</td>\n   <td>$13.25</td>\n   <td>63%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Among these six stocks, Walmart Inc. <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a>, Albertsons Cos. <a href=\"https://laohu8.com/S/ACI.UK\">$(ACI.UK)$</a> and Arko Corp. (ARKO.TV) have majority \"buy\" or equivalent ratings, with Albertson trading well above the consensus target price.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> -- Kroger and Sprouts Farmers Markets Inc. <a href=\"https://laohu8.com/S/SFM\">$(SFM)$</a> -- have 25% \"sell\" or equivalent ratings. That is a dubious distinction, considering that analysts who work for brokerage firms tend to shy away from negative ratings. Only 5% of the S&amp;P 500 have 25% or more \"sell\" ratings.</p>\n<p>Here's a look at sales estimates (in millions) for the group of six food retailers for calendar years going out to 2025, with projected compound annual growth rates (CAGR):</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Projected sales CAGR</td>\n   <td>Est. sales -- 2020</td>\n   <td>Est. sales -- 2021</td>\n   <td>Est. sales -- 2022</td>\n   <td>Est. sales -- 2023</td>\n   <td>Est. sales -- 2024</td>\n   <td>Est. sales -- 2025</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>2.2%</td>\n   <td>$556,334</td>\n   <td>$555,252</td>\n   <td>$569,243</td>\n   <td>$589,791</td>\n   <td>$607,056</td>\n   <td>$619,743</td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>2.2%</td>\n   <td>$131,133</td>\n   <td>$132,473</td>\n   <td>$134,412</td>\n   <td>$136,506</td>\n   <td>$141,695</td>\n   <td>$146,252</td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>1.8%</td>\n   <td>$68,664</td>\n   <td>$67,714</td>\n   <td>$68,412</td>\n   <td>$70,006</td>\n   <td>$72,540</td>\n   <td>$75,056</td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc. SFM</td>\n   <td>5.6%</td>\n   <td>$6,468</td>\n   <td>$6,202</td>\n   <td>$6,665</td>\n   <td>$7,230</td>\n   <td>$7,826</td>\n   <td>$8,491</td>\n  </tr>\n  <tr>\n   <td>Grocery Outlet Holding Corp. GO</td>\n   <td>7.4%</td>\n   <td>$3,135</td>\n   <td>$3,104</td>\n   <td>$3,444</td>\n   <td>$3,842</td>\n   <td>$4,068</td>\n   <td>$4,477</td>\n  </tr>\n  <tr>\n   <td>Arko Corp. ARKO</td>\n   <td>18.3%</td>\n   <td>$3,911</td>\n   <td>$7,366</td>\n   <td>$7,749</td>\n   <td>$8,299</td>\n   <td>$8,713</td>\n   <td>$9,060</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>For sales and earnings, we are using estimates for 2020 because some fiscal periods don't even match calendar quarter-end dates.</p>\n<p>Kroger is in the bottom half of that list.</p>\n<p>Even if a company's profits are increasing slowly, its earnings per share can be boosted if it buys back enough stock to lower the average share count. Kroger announced a new $1 billion share buyback program in June. This means the company's board of directors is confident the supermarket chain will have plenty of free cash flow beyond what it will need to fund its planned digital transformation.</p>\n<p>Here's a set of estimates for earnings per share, with projected CAGR:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Projected EPS CAGR</td>\n   <td>Est. net income -- 2020</td>\n   <td>Est. net income -- 2021</td>\n   <td>Est. net income -- 2022</td>\n   <td>Est. net income -- 2023</td>\n   <td>Est. net income -- 2024</td>\n   <td>Est. net income -- 2025</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>7.2%</td>\n   <td>$5.44</td>\n   <td>$5.96</td>\n   <td>$6.30</td>\n   <td>$6.85</td>\n   <td>$7.38</td>\n   <td>$7.70</td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>0.4%</td>\n   <td>$3.37</td>\n   <td>$3.10</td>\n   <td>$3.06</td>\n   <td>$3.13</td>\n   <td>$3.36</td>\n   <td>$3.43</td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>-1.1%</td>\n   <td>$2.79</td>\n   <td>$2.36</td>\n   <td>$2.21</td>\n   <td>$2.34</td>\n   <td>$2.48</td>\n   <td>$2.63</td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc. SFM</td>\n   <td>6.7%</td>\n   <td>$2.48</td>\n   <td>$1.97</td>\n   <td>$2.08</td>\n   <td>$2.34</td>\n   <td>$2.90</td>\n   <td>$3.43</td>\n  </tr>\n  <tr>\n   <td>Grocery Outlet Holding Corp. GO</td>\n   <td>3.9%</td>\n   <td>$1.15</td>\n   <td>$0.88</td>\n   <td>$1.01</td>\n   <td>$1.14</td>\n   <td>$1.23</td>\n   <td>$1.39</td>\n  </tr>\n  <tr>\n   <td>Arko Corp. ARKO</td>\n   <td>24.7%</td>\n   <td>$0.27</td>\n   <td>$0.35</td>\n   <td>$0.43</td>\n   <td>$0.53</td>\n   <td>$0.67</td>\n   <td>$0.81</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>As you can see, Kroger is expected to see an earnings decline. Rival Walmart is expected to achieve a respectable EPS CAGR.</p>\n<p>So a lot is riding on Kroger's big bet that people will increasingly shop for food online instead of walking the store aisles. Buffett is a believer, and when considering how much shopping habits have changed for non-food items, he may have picked another long-term winner.</p>\n<p>Don't miss: These stocks provide a better way to invest in the electric-vehicle revolution than the car makers themselves</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett bucks Wall Street by adding more Kroger stock to his portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett bucks Wall Street by adding more Kroger stock to his portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-02 13:21</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kroger can be seen as both a value pick and a long-term play on the transformation of food shopping</p>\n<p>When investors think about the supermarket industry, dynamic growth probably doesn't come to mind. But Berkshire Hathaway CEO Warren Buffett loves Kroger.</p>\n<p>One reason may be that the stock is cheaply priced relative to earnings estimates. Another is that Kroger Co. KR is ramping up online sales; digital sales increased 16% in the fiscal first quarter ended May 22 from a year earlier and more than doubled from two years earlier. More growth could come from the food retailer's plans to build fulfillment centers to handle digital orders.</p>\n<p>Berkshire Hathaway Inc. (BRKA)(BRKA) purchased nearly 11 million shares of Kroger in the second quarter, according to its latest 13F report with the Securities and Exchange Commission. That brings its stake to 61.8 million shares, or about 8.3% of shares outstanding as of May 22, the end of Kroger's fiscal first quarter.</p>\n<p>Read:Warren Buffett's Berkshire Hathaway buys Kroger, cuts stakes in drug makers</p>\n<p>Wall Street doesn't like Kroger</p>\n<p>While Berkshire appears fond of Kroger, which operates as Harris Teeter, Fred Keyer and King Soopers, among others, as well as Kroger, Wall Street is more skeptical.</p>\n<p>Within the Russell 3000 Index, which represents about 98% of the U.S. stock market by market capitalization, there are only 10 companies in the \"food retail\" industry group, according to FactSet. Here they are, sorted by market capitalization, along with forward price-to-earnings ratios.</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Market cap. ($mil)</td>\n   <td>Forward P/E</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>$422,424</td>\n   <td>24.9</td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>$32,467</td>\n   <td>15.0</td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>$13,688</td>\n   <td>13.5</td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc. SFM</td>\n   <td>$2,767</td>\n   <td>12.3</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GO\">Grocery Outlet Holding</a> Corp. GO</td>\n   <td>$2,565</td>\n   <td>27.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WMK\">Weis Markets Inc</a>. WMK</td>\n   <td>$1,502</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>Arko Corp. ARKO</td>\n   <td>$1,033</td>\n   <td>16.5</td>\n  </tr>\n  <tr>\n   <td>Ingles Markets Inc. Class A IMKTA</td>\n   <td>$917</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>Natural Grocers by Vitamin Cottage Inc. NGVC</td>\n   <td>$264</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/VLGEA\">Village Super Market</a> Inc. Class A VLGEA</td>\n   <td>$233</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td></td>\n   <td>For comparison, the S&amp;P 500 index</td>\n   <td>has a weighted forward P/E of 21.4, according to FactSet.</td>\n  </tr>\n </tbody>\n</table>\n<p>There are no P/E ratios for four of these companies because consensus earnings estimates aren't available. Three aren't covered by any analysts polled by FactSet, while Natural Grocers by Vitamin Cottage Inc. <a href=\"https://laohu8.com/S/NGVC\">$(NGVC)$</a> is covered by only <a href=\"https://laohu8.com/S/AONE.U\">one</a> analyst.</p>\n<p>For the six companies covered by at least four analysts, here's a summary of ratings and price targets:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Share \"buy\" ratings</td>\n   <td>Share</td>\n   <td>neutral ratings</td>\n   <td>Share \"sell\" ratings</td>\n   <td>Closing price -- Aug. 16</td>\n   <td>Consensus price target</td>\n   <td>implied 12-month upside potential</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>75%</td>\n   <td>19%</td>\n   <td>6%</td>\n   <td>$152.34</td>\n   <td>$165.10</td>\n   <td>8%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>21%</td>\n   <td>54%</td>\n   <td>25%</td>\n   <td>$45.43</td>\n   <td>$38.49</td>\n   <td>-15%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>55%</td>\n   <td>40%</td>\n   <td>5%</td>\n   <td>$30.04</td>\n   <td>$25.28</td>\n   <td>-16%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc.</td>\n   <td>25%</td>\n   <td>50%</td>\n   <td>25%</td>\n   <td>$24.55</td>\n   <td>$26.50</td>\n   <td>8%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Grocery Outlet Holding Corp.</td>\n   <td>33%</td>\n   <td>60%</td>\n   <td>7%</td>\n   <td>$26.63</td>\n   <td>$34.36</td>\n   <td>29%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Arko Corp.</td>\n   <td>100%</td>\n   <td>0%</td>\n   <td>0%</td>\n   <td>$8.15</td>\n   <td>$13.25</td>\n   <td>63%</td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Among these six stocks, Walmart Inc. <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a>, Albertsons Cos. <a href=\"https://laohu8.com/S/ACI.UK\">$(ACI.UK)$</a> and Arko Corp. (ARKO.TV) have majority \"buy\" or equivalent ratings, with Albertson trading well above the consensus target price.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> -- Kroger and Sprouts Farmers Markets Inc. <a href=\"https://laohu8.com/S/SFM\">$(SFM)$</a> -- have 25% \"sell\" or equivalent ratings. That is a dubious distinction, considering that analysts who work for brokerage firms tend to shy away from negative ratings. Only 5% of the S&amp;P 500 have 25% or more \"sell\" ratings.</p>\n<p>Here's a look at sales estimates (in millions) for the group of six food retailers for calendar years going out to 2025, with projected compound annual growth rates (CAGR):</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Projected sales CAGR</td>\n   <td>Est. sales -- 2020</td>\n   <td>Est. sales -- 2021</td>\n   <td>Est. sales -- 2022</td>\n   <td>Est. sales -- 2023</td>\n   <td>Est. sales -- 2024</td>\n   <td>Est. sales -- 2025</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>2.2%</td>\n   <td>$556,334</td>\n   <td>$555,252</td>\n   <td>$569,243</td>\n   <td>$589,791</td>\n   <td>$607,056</td>\n   <td>$619,743</td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>2.2%</td>\n   <td>$131,133</td>\n   <td>$132,473</td>\n   <td>$134,412</td>\n   <td>$136,506</td>\n   <td>$141,695</td>\n   <td>$146,252</td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>1.8%</td>\n   <td>$68,664</td>\n   <td>$67,714</td>\n   <td>$68,412</td>\n   <td>$70,006</td>\n   <td>$72,540</td>\n   <td>$75,056</td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc. SFM</td>\n   <td>5.6%</td>\n   <td>$6,468</td>\n   <td>$6,202</td>\n   <td>$6,665</td>\n   <td>$7,230</td>\n   <td>$7,826</td>\n   <td>$8,491</td>\n  </tr>\n  <tr>\n   <td>Grocery Outlet Holding Corp. GO</td>\n   <td>7.4%</td>\n   <td>$3,135</td>\n   <td>$3,104</td>\n   <td>$3,444</td>\n   <td>$3,842</td>\n   <td>$4,068</td>\n   <td>$4,477</td>\n  </tr>\n  <tr>\n   <td>Arko Corp. ARKO</td>\n   <td>18.3%</td>\n   <td>$3,911</td>\n   <td>$7,366</td>\n   <td>$7,749</td>\n   <td>$8,299</td>\n   <td>$8,713</td>\n   <td>$9,060</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>For sales and earnings, we are using estimates for 2020 because some fiscal periods don't even match calendar quarter-end dates.</p>\n<p>Kroger is in the bottom half of that list.</p>\n<p>Even if a company's profits are increasing slowly, its earnings per share can be boosted if it buys back enough stock to lower the average share count. Kroger announced a new $1 billion share buyback program in June. This means the company's board of directors is confident the supermarket chain will have plenty of free cash flow beyond what it will need to fund its planned digital transformation.</p>\n<p>Here's a set of estimates for earnings per share, with projected CAGR:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Projected EPS CAGR</td>\n   <td>Est. net income -- 2020</td>\n   <td>Est. net income -- 2021</td>\n   <td>Est. net income -- 2022</td>\n   <td>Est. net income -- 2023</td>\n   <td>Est. net income -- 2024</td>\n   <td>Est. net income -- 2025</td>\n  </tr>\n  <tr>\n   <td>Walmart Inc. WMT</td>\n   <td>7.2%</td>\n   <td>$5.44</td>\n   <td>$5.96</td>\n   <td>$6.30</td>\n   <td>$6.85</td>\n   <td>$7.38</td>\n   <td>$7.70</td>\n  </tr>\n  <tr>\n   <td>Kroger Co. KR</td>\n   <td>0.4%</td>\n   <td>$3.37</td>\n   <td>$3.10</td>\n   <td>$3.06</td>\n   <td>$3.13</td>\n   <td>$3.36</td>\n   <td>$3.43</td>\n  </tr>\n  <tr>\n   <td>Albertsons Cos. Inc. Class A ACI</td>\n   <td>-1.1%</td>\n   <td>$2.79</td>\n   <td>$2.36</td>\n   <td>$2.21</td>\n   <td>$2.34</td>\n   <td>$2.48</td>\n   <td>$2.63</td>\n  </tr>\n  <tr>\n   <td>Sprouts Farmers Markets Inc. SFM</td>\n   <td>6.7%</td>\n   <td>$2.48</td>\n   <td>$1.97</td>\n   <td>$2.08</td>\n   <td>$2.34</td>\n   <td>$2.90</td>\n   <td>$3.43</td>\n  </tr>\n  <tr>\n   <td>Grocery Outlet Holding Corp. GO</td>\n   <td>3.9%</td>\n   <td>$1.15</td>\n   <td>$0.88</td>\n   <td>$1.01</td>\n   <td>$1.14</td>\n   <td>$1.23</td>\n   <td>$1.39</td>\n  </tr>\n  <tr>\n   <td>Arko Corp. ARKO</td>\n   <td>24.7%</td>\n   <td>$0.27</td>\n   <td>$0.35</td>\n   <td>$0.43</td>\n   <td>$0.53</td>\n   <td>$0.67</td>\n   <td>$0.81</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>As you can see, Kroger is expected to see an earnings decline. Rival Walmart is expected to achieve a respectable EPS CAGR.</p>\n<p>So a lot is riding on Kroger's big bet that people will increasingly shop for food online instead of walking the store aisles. Buffett is a believer, and when considering how much shopping habits have changed for non-food items, he may have picked another long-term winner.</p>\n<p>Don't miss: These stocks provide a better way to invest in the electric-vehicle revolution than the car makers themselves</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WMT":"沃尔玛","KR":"克罗格","SFM":"Sprouts Farmers Market Inc","ACI":"艾伯森"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172618769","content_text":"Kroger can be seen as both a value pick and a long-term play on the transformation of food shopping\nWhen investors think about the supermarket industry, dynamic growth probably doesn't come to mind. But Berkshire Hathaway CEO Warren Buffett loves Kroger.\nOne reason may be that the stock is cheaply priced relative to earnings estimates. Another is that Kroger Co. KR is ramping up online sales; digital sales increased 16% in the fiscal first quarter ended May 22 from a year earlier and more than doubled from two years earlier. More growth could come from the food retailer's plans to build fulfillment centers to handle digital orders.\nBerkshire Hathaway Inc. (BRKA)(BRKA) purchased nearly 11 million shares of Kroger in the second quarter, according to its latest 13F report with the Securities and Exchange Commission. That brings its stake to 61.8 million shares, or about 8.3% of shares outstanding as of May 22, the end of Kroger's fiscal first quarter.\nRead:Warren Buffett's Berkshire Hathaway buys Kroger, cuts stakes in drug makers\nWall Street doesn't like Kroger\nWhile Berkshire appears fond of Kroger, which operates as Harris Teeter, Fred Keyer and King Soopers, among others, as well as Kroger, Wall Street is more skeptical.\nWithin the Russell 3000 Index, which represents about 98% of the U.S. stock market by market capitalization, there are only 10 companies in the \"food retail\" industry group, according to FactSet. Here they are, sorted by market capitalization, along with forward price-to-earnings ratios.\n\n\n\nCompany\nMarket cap. ($mil)\nForward P/E\n\n\nWalmart Inc. WMT\n$422,424\n24.9\n\n\nKroger Co. KR\n$32,467\n15.0\n\n\nAlbertsons Cos. Inc. Class A ACI\n$13,688\n13.5\n\n\nSprouts Farmers Markets Inc. SFM\n$2,767\n12.3\n\n\nGrocery Outlet Holding Corp. GO\n$2,565\n27.9\n\n\nWeis Markets Inc. WMK\n$1,502\nN/A\n\n\nArko Corp. ARKO\n$1,033\n16.5\n\n\nIngles Markets Inc. Class A IMKTA\n$917\nN/A\n\n\nNatural Grocers by Vitamin Cottage Inc. NGVC\n$264\nN/A\n\n\nVillage Super Market Inc. Class A VLGEA\n$233\nN/A\n\n\nSource: FactSet\n\n\n\n\n\nFor comparison, the S&P 500 index\nhas a weighted forward P/E of 21.4, according to FactSet.\n\n\n\nThere are no P/E ratios for four of these companies because consensus earnings estimates aren't available. Three aren't covered by any analysts polled by FactSet, while Natural Grocers by Vitamin Cottage Inc. $(NGVC)$ is covered by only one analyst.\nFor the six companies covered by at least four analysts, here's a summary of ratings and price targets:\n\n\n\nCompany\nShare \"buy\" ratings\nShare\nneutral ratings\nShare \"sell\" ratings\nClosing price -- Aug. 16\nConsensus price target\nimplied 12-month upside potential\n\n\nWalmart Inc. WMT\n75%\n19%\n6%\n$152.34\n$165.10\n8%\n\n\n\nKroger Co. KR\n21%\n54%\n25%\n$45.43\n$38.49\n-15%\n\n\n\nAlbertsons Cos. Inc. Class A ACI\n55%\n40%\n5%\n$30.04\n$25.28\n-16%\n\n\n\nSprouts Farmers Markets Inc.\n25%\n50%\n25%\n$24.55\n$26.50\n8%\n\n\n\nGrocery Outlet Holding Corp.\n33%\n60%\n7%\n$26.63\n$34.36\n29%\n\n\n\nArko Corp.\n100%\n0%\n0%\n$8.15\n$13.25\n63%\n\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\n\n\nAmong these six stocks, Walmart Inc. $(WMT)$, Albertsons Cos. $(ACI.UK)$ and Arko Corp. (ARKO.TV) have majority \"buy\" or equivalent ratings, with Albertson trading well above the consensus target price.\nTwo -- Kroger and Sprouts Farmers Markets Inc. $(SFM)$ -- have 25% \"sell\" or equivalent ratings. That is a dubious distinction, considering that analysts who work for brokerage firms tend to shy away from negative ratings. Only 5% of the S&P 500 have 25% or more \"sell\" ratings.\nHere's a look at sales estimates (in millions) for the group of six food retailers for calendar years going out to 2025, with projected compound annual growth rates (CAGR):\n\n\n\nCompany\nProjected sales CAGR\nEst. sales -- 2020\nEst. sales -- 2021\nEst. sales -- 2022\nEst. sales -- 2023\nEst. sales -- 2024\nEst. sales -- 2025\n\n\nWalmart Inc. WMT\n2.2%\n$556,334\n$555,252\n$569,243\n$589,791\n$607,056\n$619,743\n\n\nKroger Co. KR\n2.2%\n$131,133\n$132,473\n$134,412\n$136,506\n$141,695\n$146,252\n\n\nAlbertsons Cos. Inc. Class A ACI\n1.8%\n$68,664\n$67,714\n$68,412\n$70,006\n$72,540\n$75,056\n\n\nSprouts Farmers Markets Inc. SFM\n5.6%\n$6,468\n$6,202\n$6,665\n$7,230\n$7,826\n$8,491\n\n\nGrocery Outlet Holding Corp. GO\n7.4%\n$3,135\n$3,104\n$3,444\n$3,842\n$4,068\n$4,477\n\n\nArko Corp. ARKO\n18.3%\n$3,911\n$7,366\n$7,749\n$8,299\n$8,713\n$9,060\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\n\n\nFor sales and earnings, we are using estimates for 2020 because some fiscal periods don't even match calendar quarter-end dates.\nKroger is in the bottom half of that list.\nEven if a company's profits are increasing slowly, its earnings per share can be boosted if it buys back enough stock to lower the average share count. Kroger announced a new $1 billion share buyback program in June. This means the company's board of directors is confident the supermarket chain will have plenty of free cash flow beyond what it will need to fund its planned digital transformation.\nHere's a set of estimates for earnings per share, with projected CAGR:\n\n\n\nCompany\nProjected EPS CAGR\nEst. net income -- 2020\nEst. net income -- 2021\nEst. net income -- 2022\nEst. net income -- 2023\nEst. net income -- 2024\nEst. net income -- 2025\n\n\nWalmart Inc. WMT\n7.2%\n$5.44\n$5.96\n$6.30\n$6.85\n$7.38\n$7.70\n\n\nKroger Co. KR\n0.4%\n$3.37\n$3.10\n$3.06\n$3.13\n$3.36\n$3.43\n\n\nAlbertsons Cos. Inc. Class A ACI\n-1.1%\n$2.79\n$2.36\n$2.21\n$2.34\n$2.48\n$2.63\n\n\nSprouts Farmers Markets Inc. SFM\n6.7%\n$2.48\n$1.97\n$2.08\n$2.34\n$2.90\n$3.43\n\n\nGrocery Outlet Holding Corp. GO\n3.9%\n$1.15\n$0.88\n$1.01\n$1.14\n$1.23\n$1.39\n\n\nArko Corp. ARKO\n24.7%\n$0.27\n$0.35\n$0.43\n$0.53\n$0.67\n$0.81\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\n\n\nAs you can see, Kroger is expected to see an earnings decline. Rival Walmart is expected to achieve a respectable EPS CAGR.\nSo a lot is riding on Kroger's big bet that people will increasingly shop for food online instead of walking the store aisles. Buffett is a believer, and when considering how much shopping habits have changed for non-food items, he may have picked another long-term winner.\nDon't miss: These stocks provide a better way to invest in the electric-vehicle revolution than the car makers themselves","news_type":1},"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":882992340,"gmtCreate":1631637328380,"gmtModify":1631884037545,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC 20210924 48.0 PUT(AMC)$</a>Now Im showing my position, this two day sure down one for amc, because tmr appl or spy will definately go up due to iphone 13, if u want earn more money, trust me, just put for two days.&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC 20210924 48.0 PUT(AMC)$</a>Now Im showing my position, this two day sure down one for amc, because tmr appl or spy will definately go up due to iphone 13, if u want earn more money, trust me, just put for two days.&nbsp;","text":"$AMC 20210924 48.0 PUT(AMC)$Now Im showing my position, this two day sure down one for amc, because tmr appl or spy will definately go up due to iphone 13, if u want earn more money, trust me, just put for two days.","images":[{"img":"https://static.tigerbbs.com/e95db30e5d3b02d232fa6f03ef0c32ca","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":518,"commentSize":109,"repostSize":0,"link":"https://laohu8.com/post/882992340","isVote":1,"tweetType":1,"viewCount":10357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":809147140,"gmtCreate":1627354821480,"gmtModify":1633765782991,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":13,"repostSize":0,"link":"https://laohu8.com/post/809147140","repostId":"2154964378","repostType":4,"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881014625,"gmtCreate":1631281232667,"gmtModify":1631883661363,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20210917 15.0 CALL(TIGR)$</a>[呆住]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20210917 15.0 CALL(TIGR)$</a>[呆住]&nbsp;","text":"$TIGR 20210917 15.0 CALL(TIGR)$[呆住]","images":[{"img":"https://static.tigerbbs.com/ade5907d18938dd7d22e78d1dfaf2bc9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":18,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/881014625","isVote":1,"tweetType":1,"viewCount":522,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"16137948889392","authorId":"16137948889392","name":"施道中","avatar":"https://static.tigerbbs.com/d22cde7d4c851ee39bd096080dffa13f","crmLevel":1,"crmLevelSwitch":0,"idStr":"16137948889392","authorIdStr":"16137948889392"},"content":"买100张废纸牛逼，老虎自娱自乐","text":"买100张废纸牛逼，老虎自娱自乐","html":"买100张废纸牛逼，老虎自娱自乐"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":821708369,"gmtCreate":1633783732632,"gmtModify":1633783732881,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":12,"repostSize":0,"link":"https://laohu8.com/post/821708369","repostId":"1167388174","repostType":4,"repost":{"id":"1167388174","kind":"news","pubTimestamp":1633742914,"share":"https://www.laohu8.com/m/news/1167388174?lang=&edition=full","pubTime":"2021-10-09 09:28","market":"us","language":"en","title":"US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167388174","media":"renaissancecap...","summary":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the w","content":"<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.</p>\n<p>Software development platform&nbsp;<b>GitLab</b>(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.</p>\n<p>B2B payments platform&nbsp;<b>AvidXchange</b>(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.</p>\n<p><b>IHS Holding</b>(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.</p>\n<p>Orthopedic medical device company&nbsp;<b>Paragon 28</b>(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.</p>\n<p>Medical diagnostics company&nbsp;<b>Lucid Diagnostics</b>(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.</p>\n<p>ADHD drug developer&nbsp;<b>Cingulate</b>(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.</p>\n<p>Managed health plan provider&nbsp;<b>Marpai</b>(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.</p>\n<p>Dermatological drug spinoff&nbsp;<b>Biofrontera</b>(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.</p>","source":"lsy1625129603274","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 09:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GTLB":"GitLab, Inc.","LUCD":"LUCID DIAGNOSTICS INC.","IHS":"IHS Holding Ltd","AVDX":"AvidXchange Holdings, Inc"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167388174","content_text":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.\nB2B payments platform AvidXchange(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.\nIHS Holding(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.\nOrthopedic medical device company Paragon 28(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.\nMedical diagnostics company Lucid Diagnostics(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.\nADHD drug developer Cingulate(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.\nManaged health plan provider Marpai(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.\nDermatological drug spinoff Biofrontera(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815710973,"gmtCreate":1630718902292,"gmtModify":1631886702269,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/815710973","repostId":"2164803577","repostType":4,"repost":{"id":"2164803577","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630699233,"share":"https://www.laohu8.com/m/news/2164803577?lang=&edition=full","pubTime":"2021-09-04 04:00","market":"us","language":"en","title":"Tech lifts Nasdaq to record close but Wall Street mixed on jobs report","url":"https://stock-news.laohu8.com/highlight/detail?id=2164803577","media":"Reuters","summary":"Dismal August jobs report calms taper fears\nLeisure, retail employment disappoint; cruise liners slu","content":"<ul>\n <li>Dismal August jobs report calms taper fears</li>\n <li>Leisure, retail employment disappoint; cruise liners slump</li>\n <li>Banking stocks slide, shrug off jump in bond yields</li>\n</ul>\n<p>Sept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.</p>\n<p>A majority of the 11 S&amp;P sectors ended lower, with the energy and financial indexes among those finishing in the red.</p>\n<p>Banking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.</p>\n<p>\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p>\n<p>\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"</p>\n<p>Among the biggest decliners on the S&amp;P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.</p>\n<p>The labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.</p>\n<p>On Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.</p>\n<p>Despite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&amp;P movement in the wake of a wide miss on the payrolls report.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&amp;P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite&nbsp;added 32.34 points, or 0.21%, to 15,363.52.</p>\n<p>The Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and <a href=\"https://laohu8.com/S/FB\">Facebook</a>. Tech stocks tend to perform better in a low interest-rate environment.</p>\n<p>Chinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.</p>\n<p>Biotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech lifts Nasdaq to record close but Wall Street mixed on jobs report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech lifts Nasdaq to record close but Wall Street mixed on jobs report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-04 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Dismal August jobs report calms taper fears</li>\n <li>Leisure, retail employment disappoint; cruise liners slump</li>\n <li>Banking stocks slide, shrug off jump in bond yields</li>\n</ul>\n<p>Sept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.</p>\n<p>A majority of the 11 S&amp;P sectors ended lower, with the energy and financial indexes among those finishing in the red.</p>\n<p>Banking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.</p>\n<p>\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p>\n<p>\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"</p>\n<p>Among the biggest decliners on the S&amp;P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.</p>\n<p>The labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.</p>\n<p>On Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.</p>\n<p>Despite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&amp;P movement in the wake of a wide miss on the payrolls report.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&amp;P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite&nbsp;added 32.34 points, or 0.21%, to 15,363.52.</p>\n<p>The Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and <a href=\"https://laohu8.com/S/FB\">Facebook</a>. Tech stocks tend to perform better in a low interest-rate environment.</p>\n<p>Chinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.</p>\n<p>Biotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164803577","content_text":"Dismal August jobs report calms taper fears\nLeisure, retail employment disappoint; cruise liners slump\nBanking stocks slide, shrug off jump in bond yields\n\nSept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.\nA majority of the 11 S&P sectors ended lower, with the energy and financial indexes among those finishing in the red.\nBanking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.\n\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.\n\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"\nAmong the biggest decliners on the S&P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.\nThe S&P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.\nThe labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.\nOn Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.\nDespite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&P movement in the wake of a wide miss on the payrolls report.\nUnofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite added 32.34 points, or 0.21%, to 15,363.52.\nThe Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and Facebook. Tech stocks tend to perform better in a low interest-rate environment.\nChinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.\nBiotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.\n(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)","news_type":1},"isVote":1,"tweetType":1,"viewCount":69,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890772394,"gmtCreate":1628138328018,"gmtModify":1633753206827,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/890772394","repostId":"1177429885","repostType":4,"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882997741,"gmtCreate":1631637904583,"gmtModify":1631884037528,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC 20210924 48.0 PUT(AMC)$</a>guess why why I still holding?","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC 20210924 48.0 PUT(AMC)$</a>guess why why I still holding?","text":"$AMC 20210924 48.0 PUT(AMC)$guess why why I still holding?","images":[{"img":"https://static.tigerbbs.com/88bfa841f1fc06daa521e4831a4ab6e1","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":8,"repostSize":0,"link":"https://laohu8.com/post/882997741","isVote":1,"tweetType":1,"viewCount":910,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":164992904,"gmtCreate":1624164295508,"gmtModify":1634009932718,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/164992904","repostId":"1199331995","repostType":4,"repost":{"id":"1199331995","kind":"news","pubTimestamp":1624065374,"share":"https://www.laohu8.com/m/news/1199331995?lang=&edition=full","pubTime":"2021-06-19 09:16","market":"us","language":"en","title":"U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1199331995","media":"Renaissance","summary":"12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.Chinese freight platform Full Truck Alliance plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value , facilitating 22+ million fulfilled orders with GTV of nearly $8 billio","content":"<p>12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.</p>\n<p>Chinese freight platform&nbsp;<b>Full Truck Alliance</b>(YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21.</p>\n<p>Healthcare manager&nbsp;<b>Bright Health Group</b>(BHG) plans to raise $1.3 billion at a $15.4 billion market cap. Bright Health seeks to employ a more consumer-centric approach to healthcare to improve consumer experiences. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding.</p>\n<p>Data infrastructure provider&nbsp;<b>Confluent</b>(CFLT) plans to raise $713 million at a $10.0 billion market cap. Confluent data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company had more than 2,500 customers as of March 2021, with a dollar-based net retention rate of 117%.</p>\n<p>Car wash brand&nbsp;<b>Mister Car Wash</b>(MCW) plans to raise $600 million at a $5.3 billion market cap. Profitable with solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company offers a monthly subscription program called Unlimited Wash Club which had 1.4 million members as of 3/31/21, representing nearly two-thirds of total wash sales.</p>\n<p>Digital physicians network&nbsp;<b>Doximity</b>(DOCS) plans to raise $501 million at a $4.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. Fast growing and profitable, the company had over 1.8 million members as of 3/31/21, representing more than 80% of physicians across the country.</p>\n<p>Customer experience software provider&nbsp;<b>Sprinklr</b>(CXM) plans to raise $361 million at a $5.5 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has attracted more than 1,000 customers, including over 50% of the Fortune 100. Sprinklr has improved its gross margins, though cash flow swung negative in 1Q FY22.</p>\n<p>HR platform provider&nbsp;<b>First Advantage</b>(FA) plans to raise $298 million at a $2.1 billion market cap. First Advantage provides technology solutions for screening, verifications, safety, and compliance related to human capital. Profitable with positive cash flow, the company derives most of its revenues from pre-onboarding screening, performing over 75 million screens on behalf of more than 30,000 customers in 2020.</p>\n<p>Chinese social networking platform&nbsp;<b>Soulgate</b>(SSR) plans to raise $185 million at a $1.8 billion market cap. The company’s app Soul is a virtual social network created to address the drawbacks of current social media platforms. In March 2021, the company averaged 9.1 million DAUs, a 94% increase over the prior year period.</p>\n<p>Digital financial services provider&nbsp;<b>AMTD Digital</b>(HKD) plans to raise $120 million at a $1.4 billion market cap. AMTD Digital states that it is the \"fusion reactor\" at the core of the AMTD SpiderNet ecosystem, operating a comprehensive digital solutions platform in Asia. Profitable with explosive growth, the company primarily generates revenue from fees and commissions in two lines of business.</p>\n<p>Organ bioengineering company&nbsp;<b>Miromatrix Medical</b>(MIRO) plans to raise $32 million at a $162 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product.</p>\n<p>Kidney disease biotech&nbsp;<b>Unicycive Therapeutics</b>(UNCY) plans to raise $25 million at a $116 million market cap. The company’s candidates include Renazorb, which was in-licensed from Spectrum Pharmaceuticals, and UNI 494, which was in-licensed from Sphaera Pharmaceuticals. Unicycive began conducting preclinical trials on UNI 494 in 2020.</p>\n<p>Antibiotic biotech&nbsp;<b>Acurx Pharmaceuticals</b>(ACXP) plans to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year.</p>\n<table>\n <tbody>\n  <tr>\n   <th>U.S. IPO Calendar</th>\n  </tr>\n  <tr>\n   <th>Issuer Business</th>\n   <th>Deal Size Market Cap</th>\n   <th>Price Range Shares Filed</th>\n   <th>Top Bookrunners</th>\n  </tr>\n  <tr>\n   <td><p>Full Truck Alliance (YMM)</p><p>Guiyang, China</p></td>\n   <td>$1,485M$19,723M</td>\n   <td>$17 - $1982,500,000</td>\n   <td>Morgan StanleyCICC</td>\n  </tr>\n  <tr>\n   <td>Digital freight platform that connects shippers and truckers in China.</td>\n  </tr>\n  <tr>\n   <td><p>First Advantage (FA)</p><p>Atlanta, GA</p></td>\n   <td>$298M$2,097M</td>\n   <td>$13 - $1521,250,000</td>\n   <td>BarclaysBofA</td>\n  </tr>\n  <tr>\n   <td>Provides background checks and other services to corporate customers.</td>\n  </tr>\n  <tr>\n   <td><p>Sprinklr (CXM)</p><p>New York, NY</p></td>\n   <td>$361M$5,541M</td>\n   <td>$18 - $2019,000,000</td>\n   <td>Morgan StanleyJP Morgan</td>\n  </tr>\n  <tr>\n   <td>Provides customer experience management software for enterprises.</td>\n  </tr>\n  <tr>\n   <td><p>Bright Health Group (BHG)</p><p>Minneapolis, MN</p></td>\n   <td>$1,290M$15,385M</td>\n   <td>$20 - $2360,000,000</td>\n   <td>JP MorganGoldman</td>\n  </tr>\n  <tr>\n   <td>Provides health insurance and other healthcare services.</td>\n  </tr>\n  <tr>\n   <td><p>Confluent (CFLT)</p><p>Mountain View, CA</p></td>\n   <td>$713M$10,033M</td>\n   <td>$29 - $3323,000,000</td>\n   <td>Morgan StanleyJP Morgan</td>\n  </tr>\n  <tr>\n   <td>Provides an enterprise platform that collects and processes real-time data streams.</td>\n  </tr>\n  <tr>\n   <td><p>Doximity (DOCS)</p><p>San Francisco, CA</p></td>\n   <td>$501M$4,549M</td>\n   <td>$20 - $2323,300,000</td>\n   <td>Morgan StanleyGoldman</td>\n  </tr>\n  <tr>\n   <td>Professional network for physicians with telehealth and scheduling tools.</td>\n  </tr>\n  <tr>\n   <td><p>Soulgate (SSR)</p><p>Shanghai, China</p></td>\n   <td>$185M$1,824M</td>\n   <td>$13 - $1513,200,000</td>\n   <td>Morgan StanleyJefferies</td>\n  </tr>\n  <tr>\n   <td>Provides the gamified social networking app Soul in China.</td>\n  </tr>\n  <tr>\n   <td><p>Acurx Pharmaceuticals (ACXP)</p><p>Staten Island, NY</p></td>\n   <td>$15M$62M</td>\n   <td>$5 - $72,500,000</td>\n   <td>Alexander CapitalNetwork 1</td>\n  </tr>\n  <tr>\n   <td>Phase 2 biotech developing antibiotics for antibiotic-resistant pathogens.</td>\n  </tr>\n  <tr>\n   <td><p>Mister Car Wash (MCW)</p><p>Tucson, AZ</p></td>\n   <td>$600M$5,256M</td>\n   <td>$15 - $1737,500,000</td>\n   <td>BofAMorgan Stanley</td>\n  </tr>\n  <tr>\n   <td>Leading national car wash brand with 344 locations across the US.</td>\n  </tr>\n  <tr>\n   <td><p>AMTD Digital (HKD)</p><p>Hong Kong, China</p></td>\n   <td>$120M$1,388M</td>\n   <td>$6.80 - $8.2016,000,000</td>\n   <td>AMTD GlobalLoop Capital</td>\n  </tr>\n  <tr>\n   <td>Digital financial services provider being spun out of AMTD.</td>\n  </tr>\n  <tr>\n   <td><p>Miromatrix Medical (MIRO)</p><p>Eden Prairie, MN</p></td>\n   <td>$32M$162M</td>\n   <td>$7 - $94,000,000</td>\n   <td>Craig-Hallum</td>\n  </tr>\n  <tr>\n   <td>Developing novel bioengineering technology for organ transplants.</td>\n  </tr>\n  <tr>\n   <td><p>Unicycive Therapeutics (UNCY)</p><p>Los Altos, CA</p></td>\n   <td>$25M$116M</td>\n   <td>$8.50 - $10.502,635,000</td>\n   <td>Roth Cap.</td>\n  </tr>\n  <tr>\n   <td>Early-stage biotech developing in-licensed therapies for kidney disease.</td>\n  </tr>\n </tbody>\n</table>\n<p>Street research is expected for seven companies, and lock-up periods will be expiring for up to two companies.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week><strong>Renaissance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.\nChinese freight platform Full Truck Alliance(YMM) plans to raise $1.5 billion at a $19.7 billion market ...</p>\n\n<a href=\"https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CXM":"Sprinklr, Inc.","DOCS":"Doximity, Inc.","YMM":"满帮","CFLT":"Confluent, Inc.","FA":"First Advantage Corp.","MCW":"Mister Car Wash, Inc."},"source_url":"https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1199331995","content_text":"12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.\nChinese freight platform Full Truck Alliance(YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21.\nHealthcare manager Bright Health Group(BHG) plans to raise $1.3 billion at a $15.4 billion market cap. Bright Health seeks to employ a more consumer-centric approach to healthcare to improve consumer experiences. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding.\nData infrastructure provider Confluent(CFLT) plans to raise $713 million at a $10.0 billion market cap. Confluent data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company had more than 2,500 customers as of March 2021, with a dollar-based net retention rate of 117%.\nCar wash brand Mister Car Wash(MCW) plans to raise $600 million at a $5.3 billion market cap. Profitable with solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company offers a monthly subscription program called Unlimited Wash Club which had 1.4 million members as of 3/31/21, representing nearly two-thirds of total wash sales.\nDigital physicians network Doximity(DOCS) plans to raise $501 million at a $4.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. Fast growing and profitable, the company had over 1.8 million members as of 3/31/21, representing more than 80% of physicians across the country.\nCustomer experience software provider Sprinklr(CXM) plans to raise $361 million at a $5.5 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has attracted more than 1,000 customers, including over 50% of the Fortune 100. Sprinklr has improved its gross margins, though cash flow swung negative in 1Q FY22.\nHR platform provider First Advantage(FA) plans to raise $298 million at a $2.1 billion market cap. First Advantage provides technology solutions for screening, verifications, safety, and compliance related to human capital. Profitable with positive cash flow, the company derives most of its revenues from pre-onboarding screening, performing over 75 million screens on behalf of more than 30,000 customers in 2020.\nChinese social networking platform Soulgate(SSR) plans to raise $185 million at a $1.8 billion market cap. The company’s app Soul is a virtual social network created to address the drawbacks of current social media platforms. In March 2021, the company averaged 9.1 million DAUs, a 94% increase over the prior year period.\nDigital financial services provider AMTD Digital(HKD) plans to raise $120 million at a $1.4 billion market cap. AMTD Digital states that it is the \"fusion reactor\" at the core of the AMTD SpiderNet ecosystem, operating a comprehensive digital solutions platform in Asia. Profitable with explosive growth, the company primarily generates revenue from fees and commissions in two lines of business.\nOrgan bioengineering company Miromatrix Medical(MIRO) plans to raise $32 million at a $162 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product.\nKidney disease biotech Unicycive Therapeutics(UNCY) plans to raise $25 million at a $116 million market cap. The company’s candidates include Renazorb, which was in-licensed from Spectrum Pharmaceuticals, and UNI 494, which was in-licensed from Sphaera Pharmaceuticals. Unicycive began conducting preclinical trials on UNI 494 in 2020.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) plans to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year.\n\n\n\nU.S. IPO Calendar\n\n\nIssuer Business\nDeal Size Market Cap\nPrice Range Shares Filed\nTop Bookrunners\n\n\nFull Truck Alliance (YMM)Guiyang, China\n$1,485M$19,723M\n$17 - $1982,500,000\nMorgan StanleyCICC\n\n\nDigital freight platform that connects shippers and truckers in China.\n\n\nFirst Advantage (FA)Atlanta, GA\n$298M$2,097M\n$13 - $1521,250,000\nBarclaysBofA\n\n\nProvides background checks and other services to corporate customers.\n\n\nSprinklr (CXM)New York, NY\n$361M$5,541M\n$18 - $2019,000,000\nMorgan StanleyJP Morgan\n\n\nProvides customer experience management software for enterprises.\n\n\nBright Health Group (BHG)Minneapolis, MN\n$1,290M$15,385M\n$20 - $2360,000,000\nJP MorganGoldman\n\n\nProvides health insurance and other healthcare services.\n\n\nConfluent (CFLT)Mountain View, CA\n$713M$10,033M\n$29 - $3323,000,000\nMorgan StanleyJP Morgan\n\n\nProvides an enterprise platform that collects and processes real-time data streams.\n\n\nDoximity (DOCS)San Francisco, CA\n$501M$4,549M\n$20 - $2323,300,000\nMorgan StanleyGoldman\n\n\nProfessional network for physicians with telehealth and scheduling tools.\n\n\nSoulgate (SSR)Shanghai, China\n$185M$1,824M\n$13 - $1513,200,000\nMorgan StanleyJefferies\n\n\nProvides the gamified social networking app Soul in China.\n\n\nAcurx Pharmaceuticals (ACXP)Staten Island, NY\n$15M$62M\n$5 - $72,500,000\nAlexander CapitalNetwork 1\n\n\nPhase 2 biotech developing antibiotics for antibiotic-resistant pathogens.\n\n\nMister Car Wash (MCW)Tucson, AZ\n$600M$5,256M\n$15 - $1737,500,000\nBofAMorgan Stanley\n\n\nLeading national car wash brand with 344 locations across the US.\n\n\nAMTD Digital (HKD)Hong Kong, China\n$120M$1,388M\n$6.80 - $8.2016,000,000\nAMTD GlobalLoop Capital\n\n\nDigital financial services provider being spun out of AMTD.\n\n\nMiromatrix Medical (MIRO)Eden Prairie, MN\n$32M$162M\n$7 - $94,000,000\nCraig-Hallum\n\n\nDeveloping novel bioengineering technology for organ transplants.\n\n\nUnicycive Therapeutics (UNCY)Los Altos, CA\n$25M$116M\n$8.50 - $10.502,635,000\nRoth Cap.\n\n\nEarly-stage biotech developing in-licensed therapies for kidney disease.\n\n\n\nStreet research is expected for seven companies, and lock-up periods will be expiring for up to two companies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883359639,"gmtCreate":1631205506021,"gmtModify":1631886702220,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>my monthly commision is 1000 taken by tiger, tmr report cant be bad one. guys, we must wiong right now, tmr will be 20%","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>my monthly commision is 1000 taken by tiger, tmr report cant be bad one. guys, we must wiong right now, tmr will be 20%","text":"$Tiger Brokers(TIGR)$my monthly commision is 1000 taken by tiger, tmr report cant be bad one. guys, we must wiong right now, tmr will be 20%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/883359639","isVote":1,"tweetType":1,"viewCount":1534,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838632690,"gmtCreate":1629389777310,"gmtModify":1633685182376,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>能恢复20块吗？26号的财报","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>能恢复20块吗？26号的财报","text":"$Tiger Brokers(TIGR)$能恢复20块吗？26号的财报","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/838632690","isVote":1,"tweetType":1,"viewCount":1031,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3516951038925987","authorId":"3516951038925987","name":"肥肥_6993","avatar":"https://static.tigerbbs.com/645b87814060f2e30161c10de2edf6b4","crmLevel":1,"crmLevelSwitch":0,"idStr":"3516951038925987","authorIdStr":"3516951038925987"},"content":"谁说26号财报？都没公布","text":"谁说26号财报？都没公布","html":"谁说26号财报？都没公布"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823749960,"gmtCreate":1633666152501,"gmtModify":1633666153504,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/823749960","repostId":"2173194725","repostType":4,"isVote":1,"tweetType":1,"viewCount":829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":881012242,"gmtCreate":1631281156186,"gmtModify":1631883661384,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20210917 15.0 CALL(TIGR)$</a>Guys Guys, dont sell tiger now, holdd next monday will hit 20, a lot people dont believe can bounced back, but now is the best chance, china gdp is very high, now china market is a super good time to invest, buy to the moon if u trust me","listText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20210917 15.0 CALL(TIGR)$</a>Guys Guys, dont sell tiger now, holdd next monday will hit 20, a lot people dont believe can bounced back, but now is the best chance, china gdp is very high, now china market is a super good time to invest, buy to the moon if u trust me","text":"$TIGR 20210917 15.0 CALL(TIGR)$Guys Guys, dont sell tiger now, holdd next monday will hit 20, a lot people dont believe can bounced back, but now is the best chance, china gdp is very high, now china market is a super good time to invest, buy to the moon if u trust me","images":[{"img":"https://static.tigerbbs.com/3cd326d2ce3e17443307474d74bdec07","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/881012242","isVote":1,"tweetType":1,"viewCount":1050,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":834465144,"gmtCreate":1629819803188,"gmtModify":1631883751846,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>based on 52weeks report we can see that price is $6.12, and now is just $6.70, its the best timing to buy more on this. Especially buy call option just for a few dayz!!!😏","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>based on 52weeks report we can see that price is $6.12, and now is just $6.70, its the best timing to buy more on this. Especially buy call option just for a few dayz!!!😏","text":"$ContextLogic Inc.(WISH)$based on 52weeks report we can see that price is $6.12, and now is just $6.70, its the best timing to buy more on this. Especially buy call option just for a few dayz!!!😏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/834465144","isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3478712067996300","authorId":"3478712067996300","name":"一本正经","avatar":"https://static.tigerbbs.com/01b02bd160a92870ba99f3c4dab60328","crmLevel":5,"crmLevelSwitch":0,"idStr":"3478712067996300","authorIdStr":"3478712067996300"},"content":"放心 可以继续跌","text":"放心 可以继续跌","html":"放心 可以继续跌"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838627259,"gmtCreate":1629396429271,"gmtModify":1631892677949,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Let's think about Q1&nbsp;RESULT, this company had worth more than 20, just hold until next week result, Q2 To Da mooonn[666]&nbsp;[666]&nbsp;[666]&nbsp;[666]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Let's think about Q1&nbsp;RESULT, this company had worth more than 20, just hold until next week result, Q2 To Da mooonn[666]&nbsp;[666]&nbsp;[666]&nbsp;[666]&nbsp;","text":"$Tiger Brokers(TIGR)$Let's think about Q1 RESULT, this company had worth more than 20, just hold until next week result, Q2 To Da mooonn[666] [666] [666] [666]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/838627259","isVote":1,"tweetType":1,"viewCount":598,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3548223089560409","authorId":"3548223089560409","name":"耐心做时间的朋友1990","avatar":"https://static.tigerbbs.com/99bb7a65d1f93e0502217ada7fc3c861","crmLevel":2,"crmLevelSwitch":0,"idStr":"3548223089560409","authorIdStr":"3548223089560409"},"content":"大佬，二季度财报如何看？","text":"大佬，二季度财报如何看？","html":"大佬，二季度财报如何看？"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176776713,"gmtCreate":1626918478932,"gmtModify":1633769750723,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"k","listText":"k","text":"k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/176776713","repostId":"2153230536","repostType":4,"repost":{"id":"2153230536","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626916924,"share":"https://www.laohu8.com/m/news/2153230536?lang=&edition=full","pubTime":"2021-07-22 09:22","market":"hk","language":"en","title":"China Evergrande says has solved legal disputes with Guangfa Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2153230536","media":"Reuters","summary":"SHANGHAI, July 22 (Reuters) - China Evergrande , the country's most indebted developer, said in a st","content":"<p>SHANGHAI, July 22 (Reuters) - China Evergrande , the country's most indebted developer, said in a statement on Thursday it has solved legal disputes with China Guangfa Bank and that the two sides will deepen business cooperation.</p>\n<p>A court in the eastern city of Wuxi this month ordered a freeze on a 132 million yuan ($20.4 million) deposit held by Evergrande and a unit at the request of Guangfa, a court filing on a Chinese corporate information app showed.</p>\n<p>Evergrande said on Monday its loan was not due until March and that it planned to take legal action against the lender.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Evergrande says has solved legal disputes with Guangfa Bank</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Evergrande says has solved legal disputes with Guangfa Bank\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-22 09:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHANGHAI, July 22 (Reuters) - China Evergrande , the country's most indebted developer, said in a statement on Thursday it has solved legal disputes with China Guangfa Bank and that the two sides will deepen business cooperation.</p>\n<p>A court in the eastern city of Wuxi this month ordered a freeze on a 132 million yuan ($20.4 million) deposit held by Evergrande and a unit at the request of Guangfa, a court filing on a Chinese corporate information app showed.</p>\n<p>Evergrande said on Monday its loan was not due until March and that it planned to take legal action against the lender.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153230536","content_text":"SHANGHAI, July 22 (Reuters) - China Evergrande , the country's most indebted developer, said in a statement on Thursday it has solved legal disputes with China Guangfa Bank and that the two sides will deepen business cooperation.\nA court in the eastern city of Wuxi this month ordered a freeze on a 132 million yuan ($20.4 million) deposit held by Evergrande and a unit at the request of Guangfa, a court filing on a Chinese corporate information app showed.\nEvergrande said on Monday its loan was not due until March and that it planned to take legal action against the lender.","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838650456,"gmtCreate":1629396742675,"gmtModify":1631892677933,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"$Tiger Brokers(TIGR)$ HOLD HOLD HOLD, next week Monday will Jump, till report is out. Look at this week had dropp whole week, every Monday will adjust one, just like last week's Monday go up, this week Monday go down. So we hold until next week Monday because report will out soon. To the moon[开心]&nbsp;[开心]&nbsp;[财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","listText":"$Tiger Brokers(TIGR)$ HOLD HOLD HOLD, next week Monday will Jump, till report is out. Look at this week had dropp whole week, every Monday will adjust one, just like last week's Monday go up, this week Monday go down. So we hold until next week Monday because report will out soon. To the moon[开心]&nbsp;[开心]&nbsp;[财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","text":"$Tiger Brokers(TIGR)$ HOLD HOLD HOLD, next week Monday will Jump, till report is out. Look at this week had dropp whole week, every Monday will adjust one, just like last week's Monday go up, this week Monday go down. So we hold until next week Monday because report will out soon. To the moon[开心] [开心] [财迷] [财迷] [财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/838650456","isVote":1,"tweetType":1,"viewCount":1816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":170082446,"gmtCreate":1626395813685,"gmtModify":1633927187397,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/170082446","repostId":"1153640468","repostType":4,"repost":{"id":"1153640468","kind":"news","pubTimestamp":1626394542,"share":"https://www.laohu8.com/m/news/1153640468?lang=&edition=full","pubTime":"2021-07-16 08:15","market":"us","language":"en","title":"Cleveland Clinic, Mount Sinai and Providence Won’t Give Biogen’s New Alzheimer’s Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1153640468","media":"The Wall Street Journal","summary":"The three hospital operators are holding off on administering Aduhelm amid a debate over its effecti","content":"<blockquote>\n The three hospital operators are holding off on administering Aduhelm amid a debate over its effectiveness.\n</blockquote>\n<p>Three large hospitals are declining to administerBiogenInc.’sBIIB-6.79%new Alzheimer’s treatment, Aduhelm, the latest rupture to emerge from the Food and Drug Administration’s controversial approval of the drug last month.</p>\n<p>The Cleveland Clinic, Mount Sinai Health System in New York and Providence in Renton, Wash., said they wouldn’t administer Aduhelm, which is also called aducanumab, to patients amid a debate about the drug’s effectiveness and whether the FDA lowered its standards in approving the medicine.</p>\n<p>The hospitals’ moves come as some health insurers also restrict access to the therapy—unusual pushback against a drug targeting a devastating disease like Alzheimer’s that has few effective treatments.</p>\n<p>While some doctors have been eager to start prescribing the newly approved drug, others have criticized the FDA for clearing the drug before studies proved it works. The critics have also expressed concerns about whether the drug’s benefits, which appeared to be modest in studies, are worth the risks of side effects such as brain bleeding that require regular monitoring by physicians.</p>\n<p>“Clinical studies failed to demonstrate the effectiveness of Aduhelm…while documenting significant risks, like brain swelling and bleeding,” said a spokeswoman for Blue Cross and Blue Shield of North Carolina, which won’t cover the drug for its commercially insured patients.</p>\n<p>Federal officials recently began a monthslong review of whether Medicare will cover Aduhelm and under what circumstances. The vast majority of patients expected to get the drug are on Medicare, the federal insurance program for the elderly and disabled.</p>\n<p>The Cleveland Clinic won’t carry the drug in its pharmacy or provide infusions of it to patients following a review of available scientific evidence by a multidisciplinary panel of experts, a hospital spokeswoman said.</p>\n<p>Cleveland Clinic doctors, the spokeswoman said, can still prescribe the medicine, but patients will have to receive their infusions at an outside facility.</p>\n<p>Aduhelm is given with a monthly infusion, typically at an outpatient medical center. Biogenpriced the drug at $56,000 a year, though one health researcher said it will probably cost more for a typical patient.</p>\n<p>“Based on the current data regarding its safety and efficacy, we have decided not to carry Aducanumab at this time,” the Cleveland Clinic said. The hospital said it will reconsider the decision when more data are available.</p>\n<p>Mount Sinai said it won’t infuse Aduhelm until it sees the findings of a U.S. government investigation into interactions between FDA staff and Biogen during the review process. The investigation, which was requested last week by FDA Acting Commissioner Janet Woodcock,has raised concernsabout the integrity of the approval process, Mount Sinai said.</p>\n<p>“Medical decisions should be based on science and data, so it is disappointing that patients living with Alzheimer’s disease may reportedly not be able to access Aduhelm at some facilities,” a Biogen spokeswoman said. “Biogen continues to stand 100% behind Aduhelm and the clinical data that supported approval.”</p>\n<blockquote>\n <b>‘We still want to do what’s best for our patients, but we simply don’t want to make a decision we can’t sustain.’</b> \n <b>— </b> \n <i>Dr. Sam Gandy, Alzheimer’s disease expert at Mount Sinai</i>\n</blockquote>\n<p>Jason Karlawish, an Alzheimer’s specialist at the University of Pennsylvania, said the decision of some health systems to not give Aduhelm suggests an erosion of trust in the FDA’s decision making.</p>\n<p>“It’s very disturbing that we’re starting to hear health systems that rely on the FDA sending signals that they don’t trust the FDA,” Dr. Karlawish said in an interview. “I have to trust the system that puts drugs into the pharmacy so that I can prescribe them with confidence.”</p>\n<p>The New York Times earlier reported that Cleveland Clinic and Mount Sinai weren’t going to administer Aduhelm to patients.</p>\n<p>In June, theFDA approved Aduhelmbased on two large but inconclusive studies of its effect in slowing cognitive decline in people with mild Alzheimer’s symptoms.</p>\n<p>The agency issued the approval using a regulatory mechanism that allows for drugs to be cleared before they are definitively proven effective, saying the Aduhelm was reasonably likely to provide a benefit by reducing levels of a sticky protein called amyloid from the brain.</p>\n<p>The FDA approval wasmade over the objectionsof some of its own statisticians and members of an outside committee of experts convened by the agency to provide advice on the drug. Three of theoutside advisers resignedfrom the committee in protest of the FDA’s decision.</p>\n<p>The FDA subsequentlynarrowed its recommendationfor who should get the drug, to Alzheimer’s patients in the early stage of the disease.</p>\n<p>Dr. Woodcock’s request for an investigation last week prompted Mount Sinai to hold off on treating patients with Aduhelm.</p>\n<p>A Mount Sinai spokeswoman said that in addition to completion of the investigation, the hospital is awaiting the writing of “best practices” guidelines for Aduhelm by its own experts, as well as a standard review necessary for adding Aduhelm to its formulary of available drugs.</p>\n<p>Sam Gandy, a Mount Sinai professor of Alzheimer’s disease research, said he and his colleagues, who are setting guidelines for Aduhelm, were open to prescribing the drug for certain patients, although only one of Biogen’s two clinical studies appeared to show the drug worked.</p>\n<p>Dr. Woodcock’s request for an investigation, however, threw into question whether the drug was appropriately evaluated and approved in the first place, Dr. Gandy said. Over the following days, the group decided they would wait for the investigation’s conclusion before considering infusions.</p>\n<p>“I’m willing to allow for the possibility that the FDA may have the latitude to approve [Aduhelm] along this accelerated approval pathway, but not if I can’t trust the integrity of the process,” Dr. Gandy said in an interview. “We still want to do what’s best for our patients, but we simply don’t want to make a decision we can’t sustain.”</p>\n<p>Washington neurologist Nancy Isenberg, one of the Providence doctors involved in the decision to not administer Aduhelm, cited the drug’s potential for serious side effects, lack of clear benefit and high cost as reasons behind the policy. Providence, whose system includes 52 hospitals and more than 1,000 outpatient clinics, is also wary of prescribing the drug before investigators return results of an investigation of Aduhelm’s regulatory approval, she said.</p>\n<p>“I wish and I hope we can offer safe, effective and affordable treatments” for Alzheimer’s patients, Dr. Isenberg said. “At the same time, this is not that.”</p>\n<p>Resistance to Aduhelm from some hospitals and insurers may not affect Biogen, which analysts project could eventually ring up billions of dollars in sales from the drug.</p>\n<p>A fair number “of academic medical centers etc. can stay on sidelines and [the] math may still work,” Evercore ISI analyst Umer Raffat said in a research note.</p>\n<p>Some skeptical doctors, he added, have said they won’t deny Aduhelm to interested patients.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cleveland Clinic, Mount Sinai and Providence Won’t Give Biogen’s New Alzheimer’s Drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCleveland Clinic, Mount Sinai and Providence Won’t Give Biogen’s New Alzheimer’s Drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 08:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/cleveland-clinic-mount-sinai-wont-give-biogens-new-alzheimers-drug-11626366968?mod=hp_lead_pos2><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The three hospital operators are holding off on administering Aduhelm amid a debate over its effectiveness.\n\nThree large hospitals are declining to administerBiogenInc.’sBIIB-6.79%new Alzheimer’s ...</p>\n\n<a href=\"https://www.wsj.com/articles/cleveland-clinic-mount-sinai-wont-give-biogens-new-alzheimers-drug-11626366968?mod=hp_lead_pos2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/articles/cleveland-clinic-mount-sinai-wont-give-biogens-new-alzheimers-drug-11626366968?mod=hp_lead_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153640468","content_text":"The three hospital operators are holding off on administering Aduhelm amid a debate over its effectiveness.\n\nThree large hospitals are declining to administerBiogenInc.’sBIIB-6.79%new Alzheimer’s treatment, Aduhelm, the latest rupture to emerge from the Food and Drug Administration’s controversial approval of the drug last month.\nThe Cleveland Clinic, Mount Sinai Health System in New York and Providence in Renton, Wash., said they wouldn’t administer Aduhelm, which is also called aducanumab, to patients amid a debate about the drug’s effectiveness and whether the FDA lowered its standards in approving the medicine.\nThe hospitals’ moves come as some health insurers also restrict access to the therapy—unusual pushback against a drug targeting a devastating disease like Alzheimer’s that has few effective treatments.\nWhile some doctors have been eager to start prescribing the newly approved drug, others have criticized the FDA for clearing the drug before studies proved it works. The critics have also expressed concerns about whether the drug’s benefits, which appeared to be modest in studies, are worth the risks of side effects such as brain bleeding that require regular monitoring by physicians.\n“Clinical studies failed to demonstrate the effectiveness of Aduhelm…while documenting significant risks, like brain swelling and bleeding,” said a spokeswoman for Blue Cross and Blue Shield of North Carolina, which won’t cover the drug for its commercially insured patients.\nFederal officials recently began a monthslong review of whether Medicare will cover Aduhelm and under what circumstances. The vast majority of patients expected to get the drug are on Medicare, the federal insurance program for the elderly and disabled.\nThe Cleveland Clinic won’t carry the drug in its pharmacy or provide infusions of it to patients following a review of available scientific evidence by a multidisciplinary panel of experts, a hospital spokeswoman said.\nCleveland Clinic doctors, the spokeswoman said, can still prescribe the medicine, but patients will have to receive their infusions at an outside facility.\nAduhelm is given with a monthly infusion, typically at an outpatient medical center. Biogenpriced the drug at $56,000 a year, though one health researcher said it will probably cost more for a typical patient.\n“Based on the current data regarding its safety and efficacy, we have decided not to carry Aducanumab at this time,” the Cleveland Clinic said. The hospital said it will reconsider the decision when more data are available.\nMount Sinai said it won’t infuse Aduhelm until it sees the findings of a U.S. government investigation into interactions between FDA staff and Biogen during the review process. The investigation, which was requested last week by FDA Acting Commissioner Janet Woodcock,has raised concernsabout the integrity of the approval process, Mount Sinai said.\n“Medical decisions should be based on science and data, so it is disappointing that patients living with Alzheimer’s disease may reportedly not be able to access Aduhelm at some facilities,” a Biogen spokeswoman said. “Biogen continues to stand 100% behind Aduhelm and the clinical data that supported approval.”\n\n‘We still want to do what’s best for our patients, but we simply don’t want to make a decision we can’t sustain.’\n— \nDr. Sam Gandy, Alzheimer’s disease expert at Mount Sinai\n\nJason Karlawish, an Alzheimer’s specialist at the University of Pennsylvania, said the decision of some health systems to not give Aduhelm suggests an erosion of trust in the FDA’s decision making.\n“It’s very disturbing that we’re starting to hear health systems that rely on the FDA sending signals that they don’t trust the FDA,” Dr. Karlawish said in an interview. “I have to trust the system that puts drugs into the pharmacy so that I can prescribe them with confidence.”\nThe New York Times earlier reported that Cleveland Clinic and Mount Sinai weren’t going to administer Aduhelm to patients.\nIn June, theFDA approved Aduhelmbased on two large but inconclusive studies of its effect in slowing cognitive decline in people with mild Alzheimer’s symptoms.\nThe agency issued the approval using a regulatory mechanism that allows for drugs to be cleared before they are definitively proven effective, saying the Aduhelm was reasonably likely to provide a benefit by reducing levels of a sticky protein called amyloid from the brain.\nThe FDA approval wasmade over the objectionsof some of its own statisticians and members of an outside committee of experts convened by the agency to provide advice on the drug. Three of theoutside advisers resignedfrom the committee in protest of the FDA’s decision.\nThe FDA subsequentlynarrowed its recommendationfor who should get the drug, to Alzheimer’s patients in the early stage of the disease.\nDr. Woodcock’s request for an investigation last week prompted Mount Sinai to hold off on treating patients with Aduhelm.\nA Mount Sinai spokeswoman said that in addition to completion of the investigation, the hospital is awaiting the writing of “best practices” guidelines for Aduhelm by its own experts, as well as a standard review necessary for adding Aduhelm to its formulary of available drugs.\nSam Gandy, a Mount Sinai professor of Alzheimer’s disease research, said he and his colleagues, who are setting guidelines for Aduhelm, were open to prescribing the drug for certain patients, although only one of Biogen’s two clinical studies appeared to show the drug worked.\nDr. Woodcock’s request for an investigation, however, threw into question whether the drug was appropriately evaluated and approved in the first place, Dr. Gandy said. Over the following days, the group decided they would wait for the investigation’s conclusion before considering infusions.\n“I’m willing to allow for the possibility that the FDA may have the latitude to approve [Aduhelm] along this accelerated approval pathway, but not if I can’t trust the integrity of the process,” Dr. Gandy said in an interview. “We still want to do what’s best for our patients, but we simply don’t want to make a decision we can’t sustain.”\nWashington neurologist Nancy Isenberg, one of the Providence doctors involved in the decision to not administer Aduhelm, cited the drug’s potential for serious side effects, lack of clear benefit and high cost as reasons behind the policy. Providence, whose system includes 52 hospitals and more than 1,000 outpatient clinics, is also wary of prescribing the drug before investigators return results of an investigation of Aduhelm’s regulatory approval, she said.\n“I wish and I hope we can offer safe, effective and affordable treatments” for Alzheimer’s patients, Dr. Isenberg said. “At the same time, this is not that.”\nResistance to Aduhelm from some hospitals and insurers may not affect Biogen, which analysts project could eventually ring up billions of dollars in sales from the drug.\nA fair number “of academic medical centers etc. can stay on sidelines and [the] math may still work,” Evercore ISI analyst Umer Raffat said in a research note.\nSome skeptical doctors, he added, have said they won’t deny Aduhelm to interested patients.","news_type":1},"isVote":1,"tweetType":1,"viewCount":103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151761219,"gmtCreate":1625107569431,"gmtModify":1633944704512,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"k","listText":"k","text":"k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/151761219","repostId":"1178516480","repostType":4,"repost":{"id":"1178516480","kind":"news","pubTimestamp":1625094708,"share":"https://www.laohu8.com/m/news/1178516480?lang=&edition=full","pubTime":"2021-07-01 07:11","market":"us","language":"en","title":"S&P 500 notches fifth straight record closing high, fifth straight quarterly gain","url":"https://stock-news.laohu8.com/highlight/detail?id=1178516480","media":"Reuters","summary":"NEW YORK (Reuters) - The S&P 500 nabbed its fifth straight record closing high on Wednesday as inves","content":"<p>NEW YORK (Reuters) - The S&amp;P 500 nabbed its fifth straight record closing high on Wednesday as investors ended the month and the quarter by largely shrugging off positive economic data and looking toward Friday’s highly anticipated employment report.</p>\n<p>In the last session of 2021’s first half, the indexes were languid and range-bound, with the blue-chip Dow posting gains, while the Nasdaq edged lower.</p>\n<p>All three indexes posted their fifth consecutive quarterly gains, with the S&amp;P rising 8.2%, the Nasdaq advancing 9.5% and the Dow rising 4.6%. The S&amp;P 500 registered its second-best first-half performance since 1998, rising 14.5%.</p>\n<p>“It’s been a good quarter,” said Robert Pavlik, senior portfolio manager at Dakota Wealth in Fairfield, Connecticut. “As of last night’s close, the S&amp;P has gained more than 14% year-to-date, topping the Dow and the Nasdaq. That indicates that the stock market is having a broad rally.”</p>\n<p>For the month, the bellwether S&amp;P 500 notched its fifth consecutive advance, while the Dow snapped its four-month winning streak to end slightly lower. The Nasdaq also gained ground in June.</p>\n<p>This month, investor appetite shifted away from economically sensitive cyclicals in favor of growth stocks.</p>\n<p>“Leading sectors year-to-date are what you’d expect,” Pavlik added. “Energy, financials and industrials, and that speaks to an economic environment that’s in the early stages of a cycle.”</p>\n<p>“(Investors) started the switch back to growth (stocks) after people started to buy in to (Fed Chair Jerome) Powell’s comments that focus on transitory inflation,” Pavlik added.</p>\n<p>“Some of the reopening trades have gotten a bit long in the tooth and that’s leading people back to growth.”</p>\n<p>(Graphic: Growths stocks outperform value in June, narrow YTD gap, )</p>\n<p><img src=\"https://static.tigerbbs.com/5b82b4dfdc765d913811f9d8572e60f6\" tg-width=\"964\" tg-height=\"723\" referrerpolicy=\"no-referrer\">“The overall stock market continues to be on a tear, with very consistent gains for quite some time,” said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York. “Valuations, while certainly high by historical standards, have been at a fairly consistent level, benefiting from the economic recovery.”</p>\n<p>The private sector added 692,000 jobs in June, breezing past expectations, according to payroll processor ADP. The number is 92,000 higher than the private payroll adds economists predict from the Labor Department’s more comprehensive employment report due on Friday.</p>\n<p>The Dow Jones Industrial Average rose 210.22 points, or 0.61%, to 34,502.51, the S&amp;P 500 gained 5.7 points, or 0.13%, to 4,297.5 and the Nasdaq Composite dropped 24.38 points, or 0.17%, to 14,503.95.</p>\n<p>Among the 11 major sectors in the S&amp;P, six ended the session higher, with energy enjoying the biggest percentage gain. Real estate was the day’s biggest loser.</p>\n<p>Boeing Co gained 1.6% after Germany’s defense ministry announced it would buy five of the planemaker’s P-8A maritime control aircraft, coming on the heels of United Airlines unveiling its largest-ever order for new planes.</p>\n<p>Walmart jumped 2.7% after announcing on Tuesday that it would start selling a prescription-only insulin analog.</p>\n<p>Micron Technology advanced 2.5% ahead of its quarterly earnings release, but was relatively unchanged in after-hours trading following the chipmaker’s quarterly results.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.35-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 20 new 52-week highs and no new lows; the Nasdaq Composite recorded 70 new highs and 36 new lows.</p>\n<p>Volume on U.S. exchanges was 10.85 billion shares, compared with the 11.05 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 notches fifth straight record closing high, fifth straight quarterly gain</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 notches fifth straight record closing high, fifth straight quarterly gain\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-01 07:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/us-usa-stocks/sp-500-notches-fifth-straight-record-closing-high-fifth-straight-quarterly-gain-idUSKCN2E619R><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) - The S&P 500 nabbed its fifth straight record closing high on Wednesday as investors ended the month and the quarter by largely shrugging off positive economic data and looking ...</p>\n\n<a href=\"https://www.reuters.com/article/us-usa-stocks/sp-500-notches-fifth-straight-record-closing-high-fifth-straight-quarterly-gain-idUSKCN2E619R\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.reuters.com/article/us-usa-stocks/sp-500-notches-fifth-straight-record-closing-high-fifth-straight-quarterly-gain-idUSKCN2E619R","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178516480","content_text":"NEW YORK (Reuters) - The S&P 500 nabbed its fifth straight record closing high on Wednesday as investors ended the month and the quarter by largely shrugging off positive economic data and looking toward Friday’s highly anticipated employment report.\nIn the last session of 2021’s first half, the indexes were languid and range-bound, with the blue-chip Dow posting gains, while the Nasdaq edged lower.\nAll three indexes posted their fifth consecutive quarterly gains, with the S&P rising 8.2%, the Nasdaq advancing 9.5% and the Dow rising 4.6%. The S&P 500 registered its second-best first-half performance since 1998, rising 14.5%.\n“It’s been a good quarter,” said Robert Pavlik, senior portfolio manager at Dakota Wealth in Fairfield, Connecticut. “As of last night’s close, the S&P has gained more than 14% year-to-date, topping the Dow and the Nasdaq. That indicates that the stock market is having a broad rally.”\nFor the month, the bellwether S&P 500 notched its fifth consecutive advance, while the Dow snapped its four-month winning streak to end slightly lower. The Nasdaq also gained ground in June.\nThis month, investor appetite shifted away from economically sensitive cyclicals in favor of growth stocks.\n“Leading sectors year-to-date are what you’d expect,” Pavlik added. “Energy, financials and industrials, and that speaks to an economic environment that’s in the early stages of a cycle.”\n“(Investors) started the switch back to growth (stocks) after people started to buy in to (Fed Chair Jerome) Powell’s comments that focus on transitory inflation,” Pavlik added.\n“Some of the reopening trades have gotten a bit long in the tooth and that’s leading people back to growth.”\n(Graphic: Growths stocks outperform value in June, narrow YTD gap, )\n“The overall stock market continues to be on a tear, with very consistent gains for quite some time,” said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York. “Valuations, while certainly high by historical standards, have been at a fairly consistent level, benefiting from the economic recovery.”\nThe private sector added 692,000 jobs in June, breezing past expectations, according to payroll processor ADP. The number is 92,000 higher than the private payroll adds economists predict from the Labor Department’s more comprehensive employment report due on Friday.\nThe Dow Jones Industrial Average rose 210.22 points, or 0.61%, to 34,502.51, the S&P 500 gained 5.7 points, or 0.13%, to 4,297.5 and the Nasdaq Composite dropped 24.38 points, or 0.17%, to 14,503.95.\nAmong the 11 major sectors in the S&P, six ended the session higher, with energy enjoying the biggest percentage gain. Real estate was the day’s biggest loser.\nBoeing Co gained 1.6% after Germany’s defense ministry announced it would buy five of the planemaker’s P-8A maritime control aircraft, coming on the heels of United Airlines unveiling its largest-ever order for new planes.\nWalmart jumped 2.7% after announcing on Tuesday that it would start selling a prescription-only insulin analog.\nMicron Technology advanced 2.5% ahead of its quarterly earnings release, but was relatively unchanged in after-hours trading following the chipmaker’s quarterly results.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.35-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored decliners.\nThe S&P 500 posted 20 new 52-week highs and no new lows; the Nasdaq Composite recorded 70 new highs and 36 new lows.\nVolume on U.S. exchanges was 10.85 billion shares, compared with the 11.05 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836166664,"gmtCreate":1629465920558,"gmtModify":1631892677891,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>u might cry next week if u don't buy today","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>u might cry next week if u don't buy today","text":"$Tiger Brokers(TIGR)$u might cry next week if u don't buy today","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/836166664","isVote":1,"tweetType":1,"viewCount":573,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838630299,"gmtCreate":1629389329511,"gmtModify":1633685185400,"author":{"id":"3579215123116789","authorId":"3579215123116789","name":"Steu","avatar":"https://static.tigerbbs.com/9931a7113b073148143987262a763823","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579215123116789","authorIdStr":"3579215123116789"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>大家知道几号会发财报","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>大家知道几号会发财报","text":"$Tiger Brokers(TIGR)$大家知道几号会发财报","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/838630299","isVote":1,"tweetType":1,"viewCount":1202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}